Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis
SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commer...
Gespeichert in:
| Veröffentlicht in: | PLoS medicine Jg. 18; H. 8; S. e1003735 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Public Library of Science
12.08.2021
Public Library of Science (PLoS) |
| Schlagworte: | |
| ISSN: | 1549-1676, 1549-1277, 1549-1676 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs.
We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers' instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct ≥ 25 (50.7%, 95% CI 35.6% to 65.8%) and ≥30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies' heterogeneity in design and reporting.
In this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data. |
|---|---|
| AbstractList | BackgroundSARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs.Methods and findingsWe registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers' instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct ≥ 25 (50.7%, 95% CI 35.6% to 65.8%) and ≥30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies' heterogeneity in design and reporting.ConclusionsIn this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data. SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs. We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers' instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct [greater than or equal to] 25 (50.7%, 95% CI 35.6% to 65.8%) and [greater than or equal to]30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies' heterogeneity in design and reporting. In this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data. Background SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs. Methods and findings We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers’ instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct ≥ 25 (50.7%, 95% CI 35.6% to 65.8%) and ≥30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies’ heterogeneity in design and reporting. Conclusions In this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data. Background SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs. Methods and findings We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers' instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct [greater than or equal to] 25 (50.7%, 95% CI 35.6% to 65.8%) and [greater than or equal to]30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies' heterogeneity in design and reporting. Conclusions In this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data. Background SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs. Methods and findings We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers’ instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct ≥ 25 (50.7%, 95% CI 35.6% to 65.8%) and ≥30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies’ heterogeneity in design and reporting. Conclusions In this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data. SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs. We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers' instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct ≥ 25 (50.7%, 95% CI 35.6% to 65.8%) and ≥30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies' heterogeneity in design and reporting. In this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data. SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs.BACKGROUNDSARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown variable performance. In this systematic review and meta-analysis, we assessed the clinical accuracy (sensitivity and specificity) of commercially available Ag-RDTs.We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers' instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct ≥ 25 (50.7%, 95% CI 35.6% to 65.8%) and ≥30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies' heterogeneity in design and reporting.METHODS AND FINDINGSWe registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched multiple databases (PubMed, Web of Science Core Collection, medRvix, bioRvix, and FIND) for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 up until 30 April 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity in comparison to reverse transcription polymerase chain reaction (RT-PCR) testing. We assessed heterogeneity by subgroup analyses, and rated study quality and risk of bias using the QUADAS-2 assessment tool. From a total of 14,254 articles, we included 133 analytical and clinical studies resulting in 214 clinical accuracy datasets with 112,323 samples. Across all meta-analyzed samples, the pooled Ag-RDT sensitivity and specificity were 71.2% (95% CI 68.2% to 74.0%) and 98.9% (95% CI 98.6% to 99.1%), respectively. Sensitivity increased to 76.3% (95% CI 73.1% to 79.2%) if analysis was restricted to studies that followed the Ag-RDT manufacturers' instructions. LumiraDx showed the highest sensitivity, with 88.2% (95% CI 59.0% to 97.5%). Of instrument-free Ag-RDTs, Standard Q nasal performed best, with 80.2% sensitivity (95% CI 70.3% to 87.4%). Across all Ag-RDTs, sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values, i.e., <20 (96.5%, 95% CI 92.6% to 98.4%) and <25 (95.8%, 95% CI 92.3% to 97.8%), in comparison to those with Ct ≥ 25 (50.7%, 95% CI 35.6% to 65.8%) and ≥30 (20.9%, 95% CI 12.5% to 32.8%). Testing in the first week from symptom onset resulted in substantially higher sensitivity (83.8%, 95% CI 76.3% to 89.2%) compared to testing after 1 week (61.5%, 95% CI 52.2% to 70.0%). The best Ag-RDT sensitivity was found with anterior nasal sampling (75.5%, 95% CI 70.4% to 79.9%), in comparison to other sample types (e.g., nasopharyngeal, 71.6%, 95% CI 68.1% to 74.9%), although CIs were overlapping. Concerns of bias were raised across all datasets, and financial support from the manufacturer was reported in 24.1% of datasets. Our analysis was limited by the included studies' heterogeneity in design and reporting.In this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data.CONCLUSIONSIn this study we found that Ag-RDTs detect the vast majority of SARS-CoV-2-infected persons within the first week of symptom onset and those with high viral load. Thus, they can have high utility for diagnostic purposes in the early phase of disease, making them a valuable tool to fight the spread of SARS-CoV-2. Standardization in conduct and reporting of clinical accuracy studies would improve comparability and use of data. Lukas Brümmer and co-workers report on the accuracy of rapid antigen tests for SARS-CoV-2. |
| Audience | Academic |
| Author | Katzenschlager, Stephan Ongarello, Stefano Brümmer, Lukas E. Sacks, Jilian A. Macé, Aurélien Grilli, Maurizio Pollock, Nira R. Bota, Marc Carmona, Sergio Gaeddert, Mary Schmitz, Stephani Weigand, Markus A. Denkinger, Claudia M. Erdmann, Christian Larmann, Jan |
| AuthorAffiliation | 3 FH Muenster University of Applied Sciences, Muenster, Germany 1 Division of Tropical Medicine, Center for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany 5 Library, University Medical Center Mannheim, Mannheim, Germany 7 FIND, Geneva, Switzerland 8 Partner Site Heidelberg University Hospital, German Center for Infection Research (DZIF), Heidelberg, Germany 4 Agaplesion Bethesda Hospital, Hamburg, Germany 2 Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany PLOS Medicine Editorial Board, UNITED STATES 6 Department of Laboratory Medicine, Boston Children’s Hospital, Boston, Massachusetts, United States of America |
| AuthorAffiliation_xml | – name: 1 Division of Tropical Medicine, Center for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany – name: 7 FIND, Geneva, Switzerland – name: 2 Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany – name: PLOS Medicine Editorial Board, UNITED STATES – name: 5 Library, University Medical Center Mannheim, Mannheim, Germany – name: 6 Department of Laboratory Medicine, Boston Children’s Hospital, Boston, Massachusetts, United States of America – name: 8 Partner Site Heidelberg University Hospital, German Center for Infection Research (DZIF), Heidelberg, Germany – name: 4 Agaplesion Bethesda Hospital, Hamburg, Germany – name: 3 FH Muenster University of Applied Sciences, Muenster, Germany |
| Author_xml | – sequence: 1 givenname: Lukas E. orcidid: 0000-0002-8812-7975 surname: Brümmer fullname: Brümmer, Lukas E. – sequence: 2 givenname: Stephan orcidid: 0000-0003-4977-7999 surname: Katzenschlager fullname: Katzenschlager, Stephan – sequence: 3 givenname: Mary orcidid: 0000-0002-6713-3495 surname: Gaeddert fullname: Gaeddert, Mary – sequence: 4 givenname: Christian orcidid: 0000-0003-0159-128X surname: Erdmann fullname: Erdmann, Christian – sequence: 5 givenname: Stephani orcidid: 0000-0003-1188-2750 surname: Schmitz fullname: Schmitz, Stephani – sequence: 6 givenname: Marc orcidid: 0000-0003-0265-8642 surname: Bota fullname: Bota, Marc – sequence: 7 givenname: Maurizio orcidid: 0000-0001-7649-7242 surname: Grilli fullname: Grilli, Maurizio – sequence: 8 givenname: Jan orcidid: 0000-0003-3365-4572 surname: Larmann fullname: Larmann, Jan – sequence: 9 givenname: Markus A. surname: Weigand fullname: Weigand, Markus A. – sequence: 10 givenname: Nira R. orcidid: 0000-0002-6396-2915 surname: Pollock fullname: Pollock, Nira R. – sequence: 11 givenname: Aurélien orcidid: 0000-0002-3282-1650 surname: Macé fullname: Macé, Aurélien – sequence: 12 givenname: Sergio orcidid: 0000-0002-6792-4748 surname: Carmona fullname: Carmona, Sergio – sequence: 13 givenname: Stefano surname: Ongarello fullname: Ongarello, Stefano – sequence: 14 givenname: Jilian A. orcidid: 0000-0003-4815-4693 surname: Sacks fullname: Sacks, Jilian A. – sequence: 15 givenname: Claudia M. orcidid: 0000-0002-7216-7067 surname: Denkinger fullname: Denkinger, Claudia M. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34383750$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVk11v0zAUhiM0xD7gHyCIhITgIsWunTjZBVI18VFpYtIGu7Vc5zj1lNrFTgr995zSFK1ThUC5cOQ87-v3-OScJkfOO0iS55SMKBP03Z3vg1PtaLmAekQJYYLlj5ITmvMqo4Uoju69HyenMd4RMq5IRZ4kx4yzkomcnCTzidZ9UHqdepM6v4I2Va6zDbg0qKWt09qqxvnYWR1T40N6M7m-yS78bTY-Tydpa1fWNWlcxw4WCqE0wMrCDzSp0wV0KlOYcR1tfJo8NqqN8GxYz5JvHz98vficXV59ml5MLjNdMtJlnHJTCKNYjktRgZjV45xhVqoIFkgVKCNgpsEUtALDal3M8opxGI9VyZlhZ8nLre-y9VEOlxTlOBeM5zynAonplqi9upPLYBcqrKVXVv7e8KGRKmApLUhdFzkDQUo6q7gRvCSmKgtqclIKUhiGXu-H0_oZ9kGD64Jq90z3vzg7l41fyZKVVckrNHgzGAT_vYfYyYWNGtpWOfD9JndBeVlRThF99QA9XN1ANQoLsM54PFdvTOWkEJxi8DJHKjtAYdcBQ-J_Zixu7_GjAzw-NSysPih4uydApoOfXaP6GOX05vo_2C__zl7d7rOv77FzUG03j77tO-td3Adf3O_in_btxgSB8y2gg48xgJHadmrjg9dgW0mJ3MzkriFyM5NymEkU8wfinf9fZb8ARQQ31w |
| CitedBy_id | crossref_primary_10_1186_s12916_022_02603_x crossref_primary_10_3389_fpubh_2022_1024525 crossref_primary_10_1016_j_talanta_2022_123630 crossref_primary_10_1136_bmjoq_2024_002999 crossref_primary_10_3389_fcimb_2022_960938 crossref_primary_10_1093_cid_ciac450 crossref_primary_10_1371_journal_pone_0303062 crossref_primary_10_1007_s15010_022_01975_9 crossref_primary_10_1016_j_jinf_2022_03_013 crossref_primary_10_1016_j_puhe_2021_09_035 crossref_primary_10_1186_s12874_023_01980_y crossref_primary_10_1016_j_ijid_2022_09_018 crossref_primary_10_1002_jmv_28189 crossref_primary_10_1007_s40121_022_00696_8 crossref_primary_10_1063_5_0104527 crossref_primary_10_1002_smll_202309956 crossref_primary_10_1128_spectrum_01157_22 crossref_primary_10_1186_s12985_024_02414_x crossref_primary_10_1371_journal_pone_0269997 crossref_primary_10_1038_s41598_022_07447_2 crossref_primary_10_1038_s41598_023_48892_x crossref_primary_10_1038_s41598_022_11284_8 crossref_primary_10_1016_j_ajem_2022_01_028 crossref_primary_10_1186_s12879_023_08713_y crossref_primary_10_1007_s11553_022_00970_0 crossref_primary_10_1016_j_heliyon_2023_e13190 crossref_primary_10_1016_j_lanwpc_2022_100486 crossref_primary_10_1016_j_jcvp_2023_100140 crossref_primary_10_1109_MC_2023_3235880 crossref_primary_10_1016_j_microc_2024_111126 crossref_primary_10_1016_j_jtbi_2022_111333 crossref_primary_10_1128_spectrum_03731_22 crossref_primary_10_33073_pjm_2022_022 crossref_primary_10_3389_fpubh_2022_840984 crossref_primary_10_1186_s12913_023_09704_0 crossref_primary_10_1038_s41598_024_55309_w crossref_primary_10_1016_j_cmi_2022_11_004 crossref_primary_10_1136_bmjebm_2021_111828 crossref_primary_10_1155_2022_9489067 crossref_primary_10_1016_j_puhe_2025_105903 crossref_primary_10_1371_journal_pone_0266375 crossref_primary_10_1016_j_jcv_2022_105214 crossref_primary_10_1038_s41588_022_01267_w crossref_primary_10_1016_j_jcv_2025_105851 crossref_primary_10_1016_j_bjid_2025_104520 crossref_primary_10_1016_j_cmi_2022_10_028 crossref_primary_10_1016_j_jpbao_2025_100071 crossref_primary_10_1056_NEJMcp2117115 crossref_primary_10_1093_infdis_jiac333 crossref_primary_10_1093_jalm_jfae010 crossref_primary_10_2217_imt_2022_0135 crossref_primary_10_1371_journal_pmed_1003825 crossref_primary_10_1038_s41598_023_37893_5 crossref_primary_10_1097_JCMA_0000000000000626 crossref_primary_10_1136_bmj_2022_071374 crossref_primary_10_1016_j_trac_2024_117630 crossref_primary_10_1038_s43856_022_00147_y crossref_primary_10_1371_journal_pmed_1004011 crossref_primary_10_1016_j_jhep_2022_03_028 crossref_primary_10_1016_j_jcv_2022_105222 crossref_primary_10_1371_journal_pone_0327746 crossref_primary_10_1371_journal_pone_0290575 crossref_primary_10_1016_j_jcv_2024_105706 crossref_primary_10_1002_jmv_27679 crossref_primary_10_1038_s41598_023_37872_w crossref_primary_10_3889_oamjms_2023_11298 crossref_primary_10_2478_amb_2023_0035 crossref_primary_10_1016_j_bbrc_2023_06_067 crossref_primary_10_1097_QMH_0000000000000404 crossref_primary_10_3389_fpubh_2022_995249 crossref_primary_10_1038_s41598_022_12015_9 crossref_primary_10_1002_jia2_25882 crossref_primary_10_1093_cid_ciac814 crossref_primary_10_3389_fmolb_2022_801309 crossref_primary_10_1080_08870446_2024_2305644 crossref_primary_10_1038_s41579_022_00822_w crossref_primary_10_1002_jmv_28537 crossref_primary_10_1287_msom_2021_0149 crossref_primary_10_2147_CLEP_S367339 crossref_primary_10_1371_journal_pone_0284659 crossref_primary_10_3389_fmicb_2022_908525 crossref_primary_10_1093_ajcp_aqab173 crossref_primary_10_1371_journal_pone_0288612 crossref_primary_10_1186_s12916_023_02810_0 crossref_primary_10_1038_s41598_022_04826_7 crossref_primary_10_1186_s13031_024_00623_3 crossref_primary_10_3389_fmed_2022_870738 crossref_primary_10_1111_1467_9566_13694 crossref_primary_10_1007_s40664_022_00480_y crossref_primary_10_1016_j_jcv_2023_105420 crossref_primary_10_1080_14787210_2022_2070152 crossref_primary_10_1038_s41598_022_08263_4 crossref_primary_10_3389_fpubh_2022_836328 crossref_primary_10_1371_journal_pone_0285861 crossref_primary_10_1093_infdis_jiac204 crossref_primary_10_1515_cclm_2022_0360 crossref_primary_10_7554_eLife_69949 crossref_primary_10_1097_QMH_0000000000000471 crossref_primary_10_1016_j_jhin_2022_02_010 crossref_primary_10_1097_JOM_0000000000002391 crossref_primary_10_1016_j_annepidem_2023_05_002 crossref_primary_10_1002_14651858_CD014780 crossref_primary_10_1371_journal_pone_0278653 crossref_primary_10_1016_j_micpro_2023_104780 crossref_primary_10_1128_spectrum_01229_22 crossref_primary_10_7759_cureus_24173 crossref_primary_10_1128_spectrum_02455_21 crossref_primary_10_1136_bmjopen_2023_078674 crossref_primary_10_1186_s12889_022_13619_6 crossref_primary_10_1186_s12985_024_02371_5 crossref_primary_10_1136_bmjopen_2022_067591 crossref_primary_10_1017_ash_2024_82 crossref_primary_10_1093_ofid_ofad457 crossref_primary_10_1093_ofid_ofae304 crossref_primary_10_1371_journal_pone_0310939 crossref_primary_10_1371_journal_pone_0275294 crossref_primary_10_1136_bmj_2022_071215 crossref_primary_10_31362_patd_1160801 crossref_primary_10_1016_j_diagmicrobio_2022_115805 crossref_primary_10_1016_j_cll_2022_03_001 crossref_primary_10_1136_bmjresp_2023_001747 crossref_primary_10_1038_s41551_023_01028_y crossref_primary_10_7759_cureus_63294 crossref_primary_10_1038_s41598_023_46461_w crossref_primary_10_1128_spectrum_03873_22 crossref_primary_10_1016_j_jfma_2022_03_016 crossref_primary_10_2217_fvl_2021_0210 crossref_primary_10_1016_j_ebiom_2021_103774 crossref_primary_10_1016_j_cmi_2022_02_011 crossref_primary_10_1038_s41467_023_43769_z crossref_primary_10_7326_M23_0385 crossref_primary_10_1056_NEJMc2202308 crossref_primary_10_1002_rmv_2350 crossref_primary_10_1016_j_ifacol_2022_12_054 crossref_primary_10_5937_jomb0_35482 crossref_primary_10_1038_s41375_022_01578_1 crossref_primary_10_1038_s41598_023_48194_2 crossref_primary_10_3389_fmicb_2021_714242 crossref_primary_10_3389_fpubh_2023_1099116 crossref_primary_10_1136_bmjopen_2022_060832 crossref_primary_10_1186_s12879_021_06945_4 crossref_primary_10_1128_jcm_01871_22 crossref_primary_10_3389_fpubh_2021_751451 crossref_primary_10_1186_s13613_022_00986_x crossref_primary_10_1001_jamanetworkopen_2022_28143 |
| Cites_doi | 10.1002/jmv.26983 10.1093/infdis/jiaa623 10.1002/jmv.26855 10.1128/JCM.02338-20 10.1021/acs.analchem.0c01975 10.1039/D0AN01686A 10.3390/diagnostics11020363 10.1136/bmj.h5527 10.1016/j.ijid.2021.02.052 10.1016/j.ijid.2021.03.051 10.1016/S1473-3099(21)00132-8 10.1128/JCM.02593-20 10.1186/1471-2288-14-70 10.1016/j.jiac.2021.02.029 10.1016/j.jcv.2020.104684 10.1128/JCM.00083-21 10.1016/j.antiviral.2020.104882 10.1002/jmv.26830 10.1021/acsami.0c22589 10.1183/13993003.04430-2020 10.1016/j.jcv.2021.104781 10.3390/microorganisms9040798 10.7326/ACPJ202105180-056 10.1016/j.jpeds.2021.01.027 10.1016/j.eclinm.2020.100677 10.1016/S0140-6736(20)32635-0 10.1016/j.cmi.2020.11.025 10.1016/j.cmi.2020.12.022 10.3390/biom11030425 10.1016/j.jcv.2021.104796 10.1007/s12250-020-00331-1 10.1111/jpc.15405 10.1016/j.jinf.2021.02.010 10.1002/jcla.23745 10.3390/ijerph18041638 10.1007/s00430-020-00698-8 10.1016/j.microc.2020.105606 10.1371/journal.pone.0248921 10.3390/s20205871 10.1016/j.cmi.2020.11.004 10.1016/j.ijid.2020.08.029 10.1128/JCM.00260-21 10.1016/j.cmi.2020.09.057 10.1016/S2213-2600(20)30526-9 10.1021/acs.analchem.0c04608 10.1016/j.cca.2021.02.014 10.1016/j.ijid.2021.04.072 10.1007/s00430-021-00706-5 10.1016/j.bios.2020.112715 10.1021/acs.analchem.0c02288 10.1371/journal.pbio.3001216 10.1016/j.jiac.2021.01.007 10.3389/fmed.2020.00225 10.1016/j.jinf.2020.12.012 10.1016/j.jiac.2021.03.021 10.1016/j.jiac.2021.02.025 10.3201/eid2705.204688 10.3390/jcm10020328 10.1016/j.jhin.2021.01.018 10.1016/j.ijid.2021.04.065 10.3346/jkms.2021.36.e101 10.1002/jcla.23631 10.1186/s12889-021-10609-y 10.1001/jamainternmed.2020.3862 10.1021/acs.nanolett.1c00612 10.1038/s41598-021-90026-8 10.1016/j.jiac.2020.11.021 10.1007/s40121-021-00413-x 10.1186/s12985-020-01452-5 10.1016/j.jcv.2021.104785 10.1016/j.jviromet.2020.114024 10.1016/j.ajog.2021.01.002 10.1080/1354750X.2021.1876769 10.1016/j.matt.2020.09.027 10.2147/IJGM.S297762 10.1093/infdis/jiaa802 10.1016/j.jinf.2020.12.033 10.1016/j.jiac.2021.04.003 10.1016/S2666-5247(21)00056-2 10.7326/M21-0422 10.1016/j.bios.2020.112912 10.1007/s15010-020-01542-0 10.1016/j.jinf.2020.12.007 10.3201/eid2706.210226 10.1136/bmj.n71 10.3390/jcm10020265 10.1002/cbic.202000744 10.1128/JCM.00977-20 10.1371/journal.pone.0249972 10.1038/s41467-020-19925-0 10.1128/JCM.03282-20 10.1016/j.jcv.2020.104500 10.1007/s00216-021-03298-4 10.1016/j.bios.2020.112685 10.1371/journal.pone.0247606 10.1016/j.snb.2021.129899 10.1016/j.ijid.2020.10.073 10.1021/acsnano.0c02823 10.1007/s15010-020-01570-w 10.1002/jmv.26765 10.3390/pathogens10010038 10.1016/j.ijid.2021.02.098 10.1016/j.jinf.2021.02.025 10.3390/microorganisms9010058 10.1016/j.rbmo.2020.06.001 10.1016/j.jcv.2020.104654 10.7326/0003-4819-149-12-200812160-00008 10.3201/eid2702.202318 10.5772/intechopen.87410 10.1093/qjmed/hcaa185 10.1016/j.jinf.2021.04.009 10.1016/j.jcv.2020.104713 10.1016/j.jcv.2020.104712 10.1016/j.jpeds.2021.02.052 10.1016/j.aca.2021.338310 10.1016/S1473-3099(21)00152-3 10.1128/JCM.02880-20 10.7326/0003-4819-151-4-200908180-00135 10.1128/JCM.01438-20 10.1056/NEJMp2025631 10.1016/j.ijid.2021.04.048 10.1128/JCM.00842-12 10.3390/v12121420 10.3390/diagnostics11010115 10.1016/j.jiac.2021.04.010 10.1016/j.ijid.2020.12.079 10.1016/j.jinf.2020.06.042 10.1016/j.jcv.2021.104782 10.14745/ccdr.v47i01a04 10.1016/j.jiac.2020.11.015 10.1016/j.jcvp.2021.100013 10.3390/v13040684 10.1016/j.jinf.2021.01.008 10.1016/j.lanwpc.2021.100115 10.5582/bst.2021.01090 10.1002/jmv.26896 10.1016/j.jcv.2020.104472 10.1136/bmj.n208 10.1016/j.jviromet.2021.114166 10.1007/s10096-021-04202-9 10.1016/j.jcv.2020.104659 10.1016/j.jviromet.2021.114165 10.1515/cclm-2021-0182 10.1016/j.ijid.2020.12.067 10.1128/JCM.00374-21 10.4102/ajlm.v9i1.1255 10.1038/s41551-020-00670-0 10.15585/mmwr.mm7003e3 10.1016/j.aca.2020.10.009 10.1186/s12985-021-01505-3 10.3390/diagnostics10080594 10.1016/j.ijid.2021.02.005 10.3126/kumj.v18i2.32942 10.1016/j.jcv.2020.104455 10.15585/mmwr.mm695152a3 10.1016/j.ijid.2020.05.098 10.3389/fcimb.2020.553837 10.1016/j.bjid.2020.04.003 10.1016/j.jcv.2021.104789 10.1016/j.cmi.2020.09.030 10.1186/s12916-021-01948-z 10.2807/1560-7917.ES.2021.26.16.2100413 10.1093/labmed/lmaa104 10.1021/acsomega.0c05421 10.1183/13993003.03961-2020 10.3390/diagnostics11040698 10.1016/j.tmaid.2020.101942 10.1002/jmv.26985 10.7326/0003-4819-155-8-201110180-00009 10.1016/j.jiac.2021.03.011 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2021 Public Library of Science 2021 Brümmer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Brümmer et al 2021 Brümmer et al |
| Copyright_xml | – notice: COPYRIGHT 2021 Public Library of Science – notice: 2021 Brümmer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Brümmer et al 2021 Brümmer et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISN ISR 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA CZK |
| DOI | 10.1371/journal.pmed.1003735 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database Proquest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals PLoS Medicine |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Meta-analysis: Rapid antigen tests for SARS-CoV-2 |
| EISSN | 1549-1676 |
| ExternalDocumentID | 2573454517 oai_doaj_org_article_cd653e7081b94f7480f9861f508706f3 PMC8389849 A674187085 34383750 10_1371_journal_pmed_1003735 |
| Genre | Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GeographicLocations | Germany |
| GeographicLocations_xml | – name: Germany |
| GrantInformation_xml | – fundername: ; – fundername: ; grantid: 300341-102 – fundername: ; grantid: 2019-32-FIND MDR |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAUCC AAWOE AAWTL AAYXX ABDBF ABUWG ACCTH ACGFO ACIHN ACPRK ACUHS ADBBV AEAQA AENEX AFFHD AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAIFH BAWUL BBTPI BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EBS EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR IOF IOV IPO ISN ISR ITC KQ8 M1P M48 MK0 O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PV9 RNS RPM RZL SV3 TR2 TUS UKHRP WOW XSB YZZ ~8M ADRAZ ADXHL ALIPV CGR CUY CVF ECM EIF H13 IPNFZ NPM RIG WOQ 3V. 7TK 7XB 8FK AZQEC COVID DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM - AAPBV ABPTK ADACO BBAFP BCGST CZK ICW M~E |
| ID | FETCH-LOGICAL-c830t-414f67fa35f6769e7bd2533751a07351aeaf7ebcef619ef3dc6b5934e22a843f3 |
| IEDL.DBID | FPL |
| ISICitedReferencesCount | 206 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000684390300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1549-1676 1549-1277 |
| IngestDate | Fri Nov 26 17:12:39 EST 2021 Fri Oct 03 12:44:21 EDT 2025 Tue Nov 04 01:54:15 EST 2025 Fri Sep 05 12:10:44 EDT 2025 Sat Nov 29 14:25:02 EST 2025 Tue Nov 11 10:15:36 EST 2025 Sat Nov 29 11:36:31 EST 2025 Tue Nov 04 18:08:15 EST 2025 Thu Nov 13 14:29:17 EST 2025 Thu Nov 13 14:33:31 EST 2025 Thu Nov 13 14:35:44 EST 2025 Thu May 22 21:23:17 EDT 2025 Mon Jul 21 06:06:09 EDT 2025 Sat Nov 29 05:34:25 EST 2025 Tue Nov 18 20:54:35 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c830t-414f67fa35f6769e7bd2533751a07351aeaf7ebcef619ef3dc6b5934e22a843f3 |
| Notes | new_version ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 I have read the journal’s policy and the authors of this manuscript have the following competing interests: CMD is a member of the Editorial Board of PLOS Medicine. |
| ORCID | 0000-0002-6792-4748 0000-0003-1188-2750 0000-0003-3365-4572 0000-0003-4815-4693 0000-0001-7649-7242 0000-0002-3282-1650 0000-0002-6713-3495 0000-0002-7216-7067 0000-0003-4977-7999 0000-0002-8812-7975 0000-0003-0265-8642 0000-0002-6396-2915 0000-0003-0159-128X |
| OpenAccessLink | http://dx.doi.org/10.1371/journal.pmed.1003735 |
| PMID | 34383750 |
| PQID | 2573454517 |
| PQPubID | 1436338 |
| ParticipantIDs | plos_journals_2573454517 doaj_primary_oai_doaj_org_article_cd653e7081b94f7480f9861f508706f3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8389849 proquest_miscellaneous_2561489141 proquest_journals_2573454517 gale_infotracmisc_A674187085 gale_infotracgeneralonefile_A674187085 gale_infotracacademiconefile_A674187085 gale_incontextgauss_ISR_A674187085 gale_incontextgauss_ISN_A674187085 gale_incontextgauss_IOV_A674187085 gale_healthsolutions_A674187085 pubmed_primary_34383750 crossref_citationtrail_10_1371_journal_pmed_1003735 crossref_primary_10_1371_journal_pmed_1003735 |
| PublicationCentury | 2000 |
| PublicationDate | 20210812 |
| PublicationDateYYYYMMDD | 2021-08-12 |
| PublicationDate_xml | – month: 8 year: 2021 text: 20210812 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PLoS medicine |
| PublicationTitleAlternate | PLoS Med |
| PublicationYear | 2021 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | M Ebrahimi (pmed.1003735.ref032) 2021 K Kronberg Jakobsen (pmed.1003735.ref120) 2021 M Pavelka (pmed.1003735.ref031) 2020 A Kritikos (pmed.1003735.ref068) 2021 E Grossi (pmed.1003735.ref088) 2021; 92 L Blairon (pmed.1003735.ref109) 2020; 129 G Seo (pmed.1003735.ref154) 2020; 14 J Bonde (pmed.1003735.ref062) 2021 P Kannian (pmed.1003735.ref199) 2021 PK Drain (pmed.1003735.ref176) 2021; 10 T Weitzel (pmed.1003735.ref295) 2020; 39 D Liu (pmed.1003735.ref149) 2020 O Bulilete (pmed.1003735.ref253) 2020 J Rodrigues (pmed.1003735.ref077) 2021; 57 M Zou (pmed.1003735.ref164) 2021; 342 T Weitzel (pmed.1003735.ref027) 2020 B Diao (pmed.1003735.ref141) 2020; 27 H Houston (pmed.1003735.ref195) 2021; 110 FJ Raimann (pmed.1003735.ref042) 2021; 35 A Ruhan (pmed.1003735.ref059) 2020; 35 A Olalekan (pmed.1003735.ref008) 2020; 9 A Nalumansi (pmed.1003735.ref278) 2020; 104 M Korenkov (pmed.1003735.ref119) 2021 S Pickering (pmed.1003735.ref223) 2021 RS Mboumba Bouassa (pmed.1003735.ref209) 2021; 106 M Ahava (pmed.1003735.ref131) 2021 H Wang (pmed.1003735.ref160) 2021 S Doron (pmed.1003735.ref087) 2021 AE James (pmed.1003735.ref197) 2021 J-M Schwob (pmed.1003735.ref287) 2020 J Dinnes (pmed.1003735.ref011) 2021; 3 R Kobayashi (pmed.1003735.ref067) 2021; 27 C Nimmo (pmed.1003735.ref041) 2021; 9 IW Pray (pmed.1003735.ref125) 2021; 69 G Turcato (pmed.1003735.ref242) 2020; 82 G Weiss (pmed.1003735.ref049) 2021; 49 M Zacharias (pmed.1003735.ref083) 2021; 27 K Yamamoto (pmed.1003735.ref130) 2021; 104 M Ciotti (pmed.1003735.ref172) 2021; 93 P Thakur (pmed.1003735.ref239) 2021 Canadian Public Health Laboratory Network (pmed.1003735.ref052) 2021; 47 J Frnda (pmed.1003735.ref057) 2021; 13 L D’Agostino McGowan (pmed.1003735.ref054) 2021 AM Abdelrazik (pmed.1003735.ref060) 2020; 52 T Toptan (pmed.1003735.ref291) 2020; 135 F Fenollar (pmed.1003735.ref258) 2020; 59 S Ricks (pmed.1003735.ref153) 2020; 19 A Lindner (pmed.1003735.ref207) 2021 C Del Vecchio (pmed.1003735.ref174) 2021 S Villaverde (pmed.1003735.ref243) 2021; 232 H Gremmels (pmed.1003735.ref263) 2020; 31 P Merino-Amador (pmed.1003735.ref276) 2020; 27 PJ Ducrest (pmed.1003735.ref142) 2021 S Kernéis (pmed.1003735.ref201) 2021 LK Kociolek (pmed.1003735.ref300) 2020; 59 B Bruzzone (pmed.1003735.ref169) 2021; 107 M Micocci (pmed.1003735.ref211) 2021 M-T Ngo Nsoga (pmed.1003735.ref214) 2021 H Maddali (pmed.1003735.ref037) 2021; 22 E Albert (pmed.1003735.ref249) 2020; 27 V Herrera (pmed.1003735.ref265) 2020 GCK Mak (pmed.1003735.ref275) 2020; 129 A Abdulrahman (pmed.1003735.ref247) 2020 I Wagenhäuser (pmed.1003735.ref244) 2021 K Boďová (pmed.1003735.ref051) 2020 S Lee (pmed.1003735.ref299) 2020; 180 AM Razmy (pmed.1003735.ref043) 2021 U Saeed (pmed.1003735.ref078) 2021; 18 F Turner (pmed.1003735.ref301) 2021 PF Whiting (pmed.1003735.ref017) 2011; 155 P Halfon (pmed.1003735.ref192) 2021 LJ Krüger (pmed.1003735.ref004) 2020 M Hledík (pmed.1003735.ref034) 2020 Á Marchán-López (pmed.1003735.ref038) 2021; 233 LO Downs (pmed.1003735.ref098) 2021; 82 J Ferguson (pmed.1003735.ref179) 2021; 19 R Thell (pmed.1003735.ref240) 2021 Y Takeuchi (pmed.1003735.ref237) 2021; 27 Z Cui (pmed.1003735.ref029) 2020 T Seitz (pmed.1003735.ref232) 2021; 93 GCK Mak (pmed.1003735.ref208) 2021; 134 LH Cazares (pmed.1003735.ref136) 2020; 92 M Masiá (pmed.1003735.ref026) 2020 JS Sanderlin (pmed.1003735.ref045) 2021; 21 A Ehrenberg (pmed.1003735.ref050) 2021 Y Kiyasu (pmed.1003735.ref090) 2021 J Zakashansky (pmed.1003735.ref162) 2020 M Pena (pmed.1003735.ref220) 2021 V Agulló (pmed.1003735.ref248) 2021; 82 SM Hicks (pmed.1003735.ref089) 2021; 223 T Scheier (pmed.1003735.ref046) 2021; 27 M Ikeda (pmed.1003735.ref024) 2020 C Conzelmann (pmed.1003735.ref139) 2020; 181 PK Cheah (pmed.1003735.ref086) 2021; 9 A Gupta (pmed.1003735.ref264) 2020; 153 CM Denkinger (pmed.1003735.ref005) 2012; 50 GA Perchetti (pmed.1003735.ref282) 2021; 59 I Yokota (pmed.1003735.ref082) 2020 S Lefever (pmed.1003735.ref206) 2021; 59 G Caruana (pmed.1003735.ref170) 2021; 9 M Di Domenico (pmed.1003735.ref140) 2021; 11 D Nörz (pmed.1003735.ref216) 2021 L Thommes (pmed.1003735.ref081) 2021; 105 C Chaimayo (pmed.1003735.ref255) 2020; 17 T Apostolou (pmed.1003735.ref084) 2021; 293 D Moher (pmed.1003735.ref015) 2009; 151 S Jungnick (pmed.1003735.ref198) 2021; 26 A Dalal (pmed.1003735.ref097) 2021 T Ishii (pmed.1003735.ref117) 2021; 27 A Scohy (pmed.1003735.ref288) 2020; 129 V Moreira (pmed.1003735.ref040) 2021; 11 BC Young (pmed.1003735.ref246) 2021; 82 BS Vadlamani (pmed.1003735.ref159) 2020; 20 JJM Stohr (pmed.1003735.ref234) 2021 MC Fitzpatrick (pmed.1003735.ref056) 2021; 397 V Caputo (pmed.1003735.ref114) 2021; 108 L Huang (pmed.1003735.ref144) 2021; 171 L Lanser (pmed.1003735.ref069) 2021; 49 RW Peeling (pmed.1003735.ref028) 2021; 21 (pmed.1003735.ref055) 2020; 4 F Colavita (pmed.1003735.ref107) 2021; 11 A Ren (pmed.1003735.ref076) 2021 pmed.1003735.ref303 K Aoki (pmed.1003735.ref061) 2020; 27 EM Matsuda (pmed.1003735.ref102) 2021; 93 W Shao (pmed.1003735.ref155) 2021; 13 N Pollock (pmed.1003735.ref225) 2021 A Marco (pmed.1003735.ref101) 2021 G Sberna (pmed.1003735.ref230) 2021; 27 SM Oh (pmed.1003735.ref073) 2021; 36 P Mertens (pmed.1003735.ref277) 2020; 7 MAC Huergo (pmed.1003735.ref035) 2021; 146 Y Kiyasu (pmed.1003735.ref118) 2021 G Menchinelli (pmed.1003735.ref210) 2021; 59 G Regev-Yochay (pmed.1003735.ref075) 2021 Y Lv (pmed.1003735.ref070) 2021; 15 OL Akingba (pmed.1003735.ref165) 2021; 1 CY Zhang (pmed.1003735.ref163) 2020; 10 I Torres (pmed.1003735.ref292) 2020; 27 N Kohmer (pmed.1003735.ref203) 2021; 10 E Shidlovskaya (pmed.1003735.ref233) 2021 N Salcedo (pmed.1003735.ref044) 2021 F Laghrib (pmed.1003735.ref036) 2021; 160 E Schuit (pmed.1003735.ref231) 2021 S Yamayoshi (pmed.1003735.ref104) 2020; 12 JH Lee (pmed.1003735.ref146) 2021; 171 MJ Mina (pmed.1003735.ref002) 2020; 383 Y Takeda (pmed.1003735.ref290) 2020 VC Haage (pmed.1003735.ref099) 2021 N Van der Moeren (pmed.1003735.ref293) 2020 LJ Krüger (pmed.1003735.ref267) 2020 N Yin (pmed.1003735.ref245) 2021; 8 A Krüttgen (pmed.1003735.ref268) 2020; 288 Y Boum (pmed.1003735.ref063) 2021; 21 S Lambert-Niclot (pmed.1003735.ref269) 2020; 58 A Ghaffari (pmed.1003735.ref058) 2021; 11 K Itoh (pmed.1003735.ref111) 2021; 27 S Mahari (pmed.1003735.ref150) 2020 V Haage (pmed.1003735.ref191) 2021; 138 I Torres (pmed.1003735.ref241) 2021; 82 M Rodgers (pmed.1003735.ref227) 2021 A Gili (pmed.1003735.ref189) 2021; 105 L Porte (pmed.1003735.ref285) 2020; 99 A Latiano (pmed.1003735.ref092) 2020; 104 KS Faíco-Filho (pmed.1003735.ref177) 2021 AK Lindner (pmed.1003735.ref272) 2021; 57 OS Kotsiou (pmed.1003735.ref108) 2021; 18 MJ Page (pmed.1003735.ref297) 2021; 372 M Shah (pmed.1003735.ref127) 2021; 73 W Stokes (pmed.1003735.ref235) 2021; 40 L Ford (pmed.1003735.ref115) 2021 F Olearo (pmed.1003735.ref279) 2020; 137 JLG Gomez Marti (pmed.1003735.ref190) 2021 A Berger (pmed.1003735.ref252) 2020; 16 A Yakoh (pmed.1003735.ref161) 2021; 176 J Favresse (pmed.1003735.ref178) 2021; 10 J Dinnes (pmed.1003735.ref007) 2020; 8 M Peña-Rodrígez (pmed.1003735.ref074) 2021; 35 Y Li (pmed.1003735.ref148) 2021; 6 A L’Huillier (pmed.1003735.ref205) 2021 B Shrestha (pmed.1003735.ref289) 2020; 18 S Hoehl (pmed.1003735.ref100) 2020 P Singh (pmed.1003735.ref157) 2020 pmed.1003735.ref186 pmed.1003735.ref185 pmed.1003735.ref188 S Renuse (pmed.1003735.ref152) 2020 pmed.1003735.ref187 pmed.1003735.ref182 pmed.1003735.ref181 W Stokes (pmed.1003735.ref080) 2021 pmed.1003735.ref184 pmed.1003735.ref183 V Schildgen (pmed.1003735.ref286) 2020; 10 F Cerutti (pmed.1003735.ref254) 2020; 132 K Miyakawa (pmed.1003735.ref071) 2021 M Homza (pmed.1003735.ref194) 2021; 13 FM Liotti (pmed.1003735.ref273) 2020; 27 A Alemany (pmed.1003735.ref250) 2020; 82 KHM Cardozo (pmed.1003735.ref135) 2020; 11 Y Takeuchi (pmed.1003735.ref238) 2021; 11 R Smith (pmed.1003735.ref079) 2021 B Nash (pmed.1003735.ref151) 2020 JH McDermott (pmed.1003735.ref039) 2020; 113 A Cubas Atienzar (pmed.1003735.ref173) 2021 P Filgueiras (pmed.1003735.ref180) 2021 A Osterman (pmed.1003735.ref219) 2021; 210 AE Jääskeläinen (pmed.1003735.ref196) 2021; 137 ET Beck (pmed.1003735.ref251) 2020; 59 L Courtellemont (pmed.1003735.ref064) 2021; 93 T Marsic (pmed.1003735.ref094) 2021; 21 N Pollock (pmed.1003735.ref224) 2021; 59 S Muhi (pmed.1003735.ref213) 2021; 9 J Li (pmed.1003735.ref093) 2021; 1154 D Basso (pmed.1003735.ref168) 2020; 517 L Lee (pmed.1003735.ref147) 2021 RM Torrente-Rodríguez (pmed.1003735.ref158) 2020; 3 N Eshghifar (pmed.1003735.ref065) 2021; 14 QL Hingrat (pmed.1003735.ref066) 2020; 27 VG Barauna (pmed.1003735.ref133) 2021; 93 G Caruana (pmed.1003735.ref171) 2021 G Pilarowski (pmed.1003735.ref283) 2020; 223 A Strömer (pmed.1003735.ref236) 2020; 9 MM Leeflang (pmed.1003735.ref014) 2008; 149 T Schleicher (pmed.1003735.ref095) 2020; 22 K Kashiwagi (pmed.1003735.ref110) 2020 Y Uwamino (pmed.1003735.ref128) 2021; 27 B Kenyeres (pmed.1003735.ref200) 2021; 293 A Lindner (pmed.1003735.ref271) 2020; 57 pmed.1003735.ref001 I Yokota (pmed.1003735.ref105) 2021 A Crozier (pmed.1003735.ref053) 2021; 372 pmed.1003735.ref006 L Azzi (pmed.1003735.ref132) 2020; 81 B Osmanodja (pmed.1003735.ref218) 2021 M Domínguez Fernández (pmed.1003735.ref175) 2021 OY Bello-Chavolla (pmed.1003735.ref096) 2021 L Porte (pmed.1003735.ref284) 2020 pmed.1003735.ref003 E Parada-Ricart (pmed.1003735.ref280) 2020 B Baro (pmed.1003735.ref167) 2021; 82 M Linares (pmed.1003735.ref270) 2020; 133 SD Stovitz (pmed.1003735.ref047) 2021; 174 BD Grant (pmed.1003735.ref143) 2020; 92 GC Mak (pmed.1003735.ref274) 2020; 133 UK COVID-19 Lateral Flow Oversight Team (pmed.1003735.ref222) 2021 W Rastawicki (pmed.1003735.ref126) 2021; 93 M Möckel (pmed.1003735.ref212) 2021; 26 M Barlev-Gross (pmed.1003735.ref134) 2021; 413 SL McKay (pmed.1003735.ref124) 2021; 174 D Ndwandwe (pmed.1003735.ref030) 2020; 37 SM Kissler (pmed.1003735.ref298) 2020 I Van Walle (pmed.1003735.ref012) 2020 G Moreno (pmed.1003735.ref103) 2021 Z Iglὁi (pmed.1003735.ref266) 2020; 27 R Castro (pmed.1003735.ref009) 2020; 24 ET Landaas (pmed.1003735.ref122) 2021; 137 N Veyrenche (pmed.1003735.ref294) 2020; 39 PM Bossuyt (pmed.1003735.ref302) 2015; 351 A Kilic (pmed.1003735.ref202) 2021; 59 WA van Enst (pmed.1003735.ref0 34644309 - PLoS Med. 2021 Oct 13;18(10):e1003825. doi: 10.1371/journal.pmed.1003825 |
| References_xml | – volume: 93 start-page: 4161 issue: 7 year: 2021 ident: pmed.1003735.ref232 article-title: Evaluation of rapid antigen tests based on saliva for the detection of SARS-CoV-2 publication-title: J Med Virol doi: 10.1002/jmv.26983 – volume: 223 start-page: 10 issue: 1 year: 2021 ident: pmed.1003735.ref089 article-title: A dual-antigen enzyme-linked immunosorbent assay allows the assessment of severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in a low-transmission setting publication-title: J Infect Dis doi: 10.1093/infdis/jiaa623 – year: 2021 ident: pmed.1003735.ref234 article-title: Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests publication-title: medRxiv – volume: 39 start-page: 3069 issue: 5 year: 2020 ident: pmed.1003735.ref294 article-title: Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission publication-title: J Med Virol doi: 10.1002/jmv.26855 – ident: pmed.1003735.ref023 – volume: 59 start-page: e02338 issue: 1 year: 2020 ident: pmed.1003735.ref296 article-title: Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test publication-title: J Clin Microbiol doi: 10.1128/JCM.02338-20 – volume: 92 start-page: 11305 issue: 16 year: 2020 ident: pmed.1003735.ref143 article-title: SARS-CoV-2 coronavirus nucleocapsid antigen-detecting half-strip lateral flow assay toward the development of point of care tests using commercially available reagents publication-title: Anal Chem doi: 10.1021/acs.analchem.0c01975 – year: 2020 ident: pmed.1003735.ref012 article-title: Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020 publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref044 article-title: Pooling of samples for SARS-CoV-2 detection using rapid antigen tests publication-title: medRxiv – volume: 146 start-page: 382 year: 2021 ident: pmed.1003735.ref035 article-title: Current advances in the detection of COVID-19 and evaluation of the humoral response publication-title: Analyst doi: 10.1039/D0AN01686A – volume: 11 start-page: 363 year: 2021 ident: pmed.1003735.ref040 article-title: Diagnosis of SARS-Cov-2 infection using specimens other than naso- and oropharyngeal swabs: a systematic review and meta-analysis publication-title: Diagnostics doi: 10.3390/diagnostics11020363 – year: 2021 ident: pmed.1003735.ref120 article-title: Detection of SARS-CoV-2 infection by rapid antigen test in comparison with RT-PCR in a public setting publication-title: medRxiv – volume: 351 start-page: h5527 year: 2015 ident: pmed.1003735.ref302 article-title: STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies publication-title: BMJ doi: 10.1136/bmj.h5527 – year: 2020 ident: pmed.1003735.ref016 article-title: Correlation of SARS-CoV-2 nucleocapsid antigen and RNA concentrations in nasopharyngeal samples from children and adults using an ultrasensitive and quantitative antigen assay publication-title: medRxiv – volume: 105 start-page: 144 year: 2021 ident: pmed.1003735.ref081 article-title: Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.02.052 – volume: 106 start-page: 8 year: 2021 ident: pmed.1003735.ref209 article-title: Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective evaluation during the COVID-19 second wave in France publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.03.051 – volume: 21 start-page: 1089 issue: 8 year: 2021 ident: pmed.1003735.ref063 article-title: Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(21)00132-8 – ident: pmed.1003735.ref184 – year: 2020 ident: pmed.1003735.ref247 article-title: Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients publication-title: medRxiv – volume: 59 start-page: e02593 issue: 1 year: 2020 ident: pmed.1003735.ref300 article-title: Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs publication-title: J Clin Microbiol doi: 10.1128/JCM.02593-20 – year: 2021 ident: pmed.1003735.ref211 article-title: Point of care testing using rapid automated antigen testing for SARS-COV-2 in care homes—an exploratory safety, usability and diagnostic agreement evaluation publication-title: medRxiv – volume: 14 start-page: 70 year: 2014 ident: pmed.1003735.ref018 article-title: Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-70 – volume: 27 start-page: 890 issue: 6 year: 2021 ident: pmed.1003735.ref237 article-title: The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: a prospective observational study in Japan publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.02.029 – volume: 133 start-page: 104684 year: 2020 ident: pmed.1003735.ref274 article-title: Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104684 – year: 2021 ident: pmed.1003735.ref214 article-title: Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2 publication-title: medRxiv – ident: pmed.1003735.ref303 – year: 2021 ident: pmed.1003735.ref096 article-title: Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref075 article-title: Real world performance of SARS-CoV-2 antigen rapid diagnostic tests in various clinical settings publication-title: medRxiv – volume: 59 start-page: e00083 issue: 5 year: 2021 ident: pmed.1003735.ref224 article-title: Performance and implementation evaluation of the Abbott BinaxNOW Rapid Antigen Test in a high-throughput drive-through community testing site in Massachusetts publication-title: J Clin Microbiol doi: 10.1128/JCM.00083-21 – volume: 181 start-page: 104882 year: 2020 ident: pmed.1003735.ref139 article-title: An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection publication-title: Antiviral Res doi: 10.1016/j.antiviral.2020.104882 – volume: 93 start-page: 2988 year: 2021 ident: pmed.1003735.ref172 article-title: Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection publication-title: J Med Virol doi: 10.1002/jmv.26830 – volume: 13 start-page: 10321 issue: 8 year: 2021 ident: pmed.1003735.ref155 article-title: Rapid detection of SARS-CoV-2 antigens using high-purity semiconducting single-walled carbon nanotube-based field-effect transistors publication-title: ACS Appl Mater Interfaces doi: 10.1021/acsami.0c22589 – year: 2021 ident: pmed.1003735.ref199 article-title: SARS-CoV2 antigen in whole mouth fluid may be a reliable rapid detection tool publication-title: Oral Dis – volume: 13 start-page: 45 issue: 1 year: 2021 ident: pmed.1003735.ref057 article-title: On pilot massive COVID-19 testing by antigen tests in Europe publication-title: Case study: Slovakia. Infect Dis Rep – volume: 57 start-page: 2004430 issue: 5 year: 2020 ident: pmed.1003735.ref271 article-title: Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab publication-title: Eur Respir J doi: 10.1183/13993003.04430-2020 – volume: 137 start-page: 104781 year: 2021 ident: pmed.1003735.ref221 article-title: Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104781 – volume: 9 start-page: 798 issue: 4 year: 2021 ident: pmed.1003735.ref170 article-title: ImplemeNting SARS-CoV-2 Rapid antigen testing in the Emergency wArd of a Swiss univErsity hospital: the INCREASE study publication-title: Microorganisms doi: 10.3390/microorganisms9040798 – ident: pmed.1003735.ref006 – year: 2021 ident: pmed.1003735.ref062 article-title: Clinical validation of point-of-care SARS-COV-2 BD Veritor antigen test by a single throat swab for rapid COVID-19 status on hospital patients predominantly without overt COVID symptoms publication-title: medRxiv – volume: 174 start-page: JC56 year: 2021 ident: pmed.1003735.ref047 article-title: In suspected SARS-CoV-2, rapid antigen detection tests had 67% to 73% sensitivity and 98% to 100% specificity publication-title: Ann Intern Med doi: 10.7326/ACPJ202105180-056 – year: 2021 ident: pmed.1003735.ref218 article-title: Diagnostic accuracy of a novel SARS-CoV-2 antigen-detecting rapid diagnostic test from standardized self-collected anterior nasal swabs publication-title: medRxiv – volume: 232 start-page: P287 year: 2021 ident: pmed.1003735.ref243 article-title: Diagnostic accuracy of the Panbio SARS-CoV-2 Antigen Rapid Test compared with RT-PCR testing of nasopharyngeal samples in the pediatric population publication-title: J Pediatr doi: 10.1016/j.jpeds.2021.01.027 – year: 2021 ident: pmed.1003735.ref118 article-title: Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals publication-title: medRxiv – volume: 31 start-page: 100677 year: 2020 ident: pmed.1003735.ref263 article-title: Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2020.100677 – volume: 397 start-page: 24 issue: 10268 year: 2021 ident: pmed.1003735.ref056 article-title: Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests publication-title: Lancet doi: 10.1016/S0140-6736(20)32635-0 – volume: 27 start-page: 789.e1 issue: 5 year: 2020 ident: pmed.1003735.ref066 article-title: Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.11.025 – year: 2021 ident: pmed.1003735.ref192 article-title: An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients publication-title: medRxiv – volume: 27 start-page: 636.E1 issue: 4 year: 2020 ident: pmed.1003735.ref292 article-title: Real-life evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.12.022 – volume: 11 start-page: 425 issue: 3 year: 2021 ident: pmed.1003735.ref107 article-title: COVID-19 Rapid antigen test as screening strategy at points of entry: experience in Lazio region, central Italy, August–October 2020 publication-title: Biomolecules doi: 10.3390/biom11030425 – volume: 8 start-page: CD013705 issue: 8 year: 2020 ident: pmed.1003735.ref007 article-title: Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection publication-title: Cochrane Database Syst Rev – year: 2021 ident: pmed.1003735.ref097 article-title: COVID-19 rapid antigen test: role in screening prior to gastrointestinal endoscopy publication-title: Clin Endosc – volume: 3 start-page: CD013705 year: 2021 ident: pmed.1003735.ref011 article-title: Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection publication-title: Cochrane Database Syst Rev – volume: 138 start-page: 104796 year: 2021 ident: pmed.1003735.ref191 article-title: Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104796 – year: 2021 ident: pmed.1003735.ref119 article-title: Reliable assessment of in vitro SARS-CoV-2 infectivity by a rapid antigen detection test publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref173 article-title: Limit of detection in different matrices of nineteen commercially available rapid antigen tests for the detection of SARS-CoV-2 publication-title: medRxiv – volume: 35 start-page: 699 year: 2020 ident: pmed.1003735.ref059 article-title: Summary of the detection kits for SARS-CoV-2 approved by the National Medical Products Administration of China and their application for diagnosis of COVID-19 publication-title: Virol Sin doi: 10.1007/s12250-020-00331-1 – volume: 57 start-page: 1078 issue: 7 year: 2021 ident: pmed.1003735.ref077 article-title: Comparison of nasopharyngeal samples for SARS-CoV-2 detection in a paediatric cohort publication-title: J Paediatr Child Health doi: 10.1111/jpc.15405 – year: 2021 ident: pmed.1003735.ref216 article-title: Multicenter evaluation of a fully automated high-throughput SARS-CoV-2 antigen immunoassay publication-title: medRxiv – volume: 82 start-page: e11 issue: 5 year: 2021 ident: pmed.1003735.ref241 article-title: Point-of-care evaluation of a rapid antigen test (CLINITEST® Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals publication-title: J Infect doi: 10.1016/j.jinf.2021.02.010 – volume: 35 start-page: e23745 year: 2021 ident: pmed.1003735.ref074 article-title: Performance evaluation of a lateral flow assays for nasopharyngeal antigen detection for SARS-CoV-2 diagnosis publication-title: J Clin Lab Anal doi: 10.1002/jcla.23745 – volume: 18 start-page: 1638 issue: 4 year: 2021 ident: pmed.1003735.ref108 article-title: Repeated antigen-based rapid diagnostic testing for estimating the coronavirus disease 2019 prevalence from the perspective of the workers’ vulnerability before and during the lockdown publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph18041638 – volume: 210 start-page: 65 issue: 1 year: 2021 ident: pmed.1003735.ref219 article-title: Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting publication-title: Med Microbiol Immunol doi: 10.1007/s00430-020-00698-8 – volume: 160 start-page: 105606 year: 2021 ident: pmed.1003735.ref036 article-title: Current progress on COVID-19 related to biosensing technologies: new opportunity for detection and monitoring of viruses publication-title: Microchem J doi: 10.1016/j.microc.2020.105606 – volume: 16 start-page: e0248921 issue: 3 year: 2020 ident: pmed.1003735.ref252 article-title: Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers publication-title: PLoS ONE doi: 10.1371/journal.pone.0248921 – ident: pmed.1003735.ref001 – year: 2021 ident: pmed.1003735.ref099 article-title: Limited specificity of SARS-CoV-2 antigen-detecting rapid diagnostic tests at low temperatures publication-title: medRxiv – volume: 20 start-page: 5871 issue: 20 year: 2020 ident: pmed.1003735.ref159 article-title: Functionalized TiO2 nanotube-based electrochemical biosensor for rapid detection of SARS-CoV-2 publication-title: Sensors doi: 10.3390/s20205871 – volume: 27 start-page: 472.e7 issue: 3 year: 2020 ident: pmed.1003735.ref249 article-title: Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.11.004 – volume: 99 start-page: 397 year: 2020 ident: pmed.1003735.ref116 article-title: Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.08.029 – volume: 59 start-page: e00260 issue: 5 year: 2021 ident: pmed.1003735.ref202 article-title: Evaluation of performance of the BD Veritor SARS-CoV-2 chromatographic immunoassay test in patients with symptoms of COVID-19 publication-title: J Clin Microbiol doi: 10.1128/JCM.00260-21 – volume: 92 start-page: e2021001 issue: S2 year: 2021 ident: pmed.1003735.ref088 article-title: Universal Sars-Cov-2 screening in pregnant women: experience from the Italian epidemic outbreak publication-title: Acta Biomed – volume: 8 start-page: 380 year: 2021 ident: pmed.1003735.ref245 article-title: SARS-CoV-2 diagnostic tests: algorithm and field evaluation from the near patient testing to the automated diagnostic platform publication-title: Front Med – year: 2021 ident: pmed.1003735.ref227 article-title: Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests publication-title: medRxiv – volume: 27 start-page: 289.e1 issue: 2 year: 2020 ident: pmed.1003735.ref141 article-title: Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.09.057 – year: 2021 ident: pmed.1003735.ref215 article-title: Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter? publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref105 article-title: Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine publication-title: medRxiv – volume: 9 start-page: e7 issue: 1 year: 2021 ident: pmed.1003735.ref041 article-title: Implementing rapid diagnostics for COVID-19 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30526-9 – volume: 93 start-page: 2950 issue: 5 year: 2021 ident: pmed.1003735.ref133 article-title: Ultrarapid on-site detection of SARS-CoV-2 infection using simple ATR-FTIR spectroscopy and an analysis algorithm: high sensitivity and specificity publication-title: Anal Chem doi: 10.1021/acs.analchem.0c04608 – ident: pmed.1003735.ref188 – volume: 517 start-page: 54 year: 2020 ident: pmed.1003735.ref168 article-title: Salivary SARS-CoV-2 antigen rapid detection: a prospective cohort study publication-title: Clin Chim Acta doi: 10.1016/j.cca.2021.02.014 – volume: 107 start-page: 215 year: 2021 ident: pmed.1003735.ref169 article-title: Comparative diagnostic performance of different rapid antigen detection tests for COVID-19 in the real-world hospital setting publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.04.072 – year: 2021 ident: pmed.1003735.ref032 article-title: Diagnostic utility of antigen detection rapid diagnostic tests for Covid- 19: a systematic review and meta-analysis publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref239 article-title: Utility of antigen-based rapid diagnostic test for detection of SARS-CoV-2 virus in routine hospital settings publication-title: Lab Med – year: 2021 ident: pmed.1003735.ref174 article-title: Emergence of N antigen SARS-CoV-2 genetic variants escaping detection of antigenic tests publication-title: medRxiv – volume: 201 start-page: 165 issue: 2–3 year: 2021 ident: pmed.1003735.ref106 article-title: Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission publication-title: Med Microbiol Immunol doi: 10.1007/s00430-021-00706-5 – volume: 171 start-page: 112715 year: 2021 ident: pmed.1003735.ref146 article-title: A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2) publication-title: Biosens Bioelectron doi: 10.1016/j.bios.2020.112715 – year: 2021 ident: pmed.1003735.ref231 article-title: Diagnostic accuracy of rapid antigen tests in pre-/asymptomatic close contacts of individuals with a confirmed SARS-CoV-2 infection publication-title: medRxiv – ident: pmed.1003735.ref259 – volume: 92 start-page: 13813 issue: 20 year: 2020 ident: pmed.1003735.ref136 article-title: Development of a parallel reaction monitoring mass spectrometry assay for the detection of SARS-CoV-2 spike glycoprotein and nucleoprotein publication-title: Anal Chem doi: 10.1021/acs.analchem.0c02288 – ident: pmed.1003735.ref260 – volume: 19 start-page: e3001216 issue: 4 year: 2021 ident: pmed.1003735.ref179 article-title: Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: testing frequency and public health messaging is key publication-title: PLoS Biol doi: 10.1371/journal.pbio.3001216 – volume: 27 start-page: 800 issue: 6 year: 2021 ident: pmed.1003735.ref067 article-title: Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.01.007 – volume: 7 start-page: 225 year: 2020 ident: pmed.1003735.ref277 article-title: Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context publication-title: Front Med doi: 10.3389/fmed.2020.00225 – volume: 82 start-page: E14 year: 2020 ident: pmed.1003735.ref242 article-title: Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report publication-title: J Infect doi: 10.1016/j.jinf.2020.12.012 – volume: 27 start-page: 1039 issue: 7 year: 2021 ident: pmed.1003735.ref166 article-title: Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-19 publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.03.021 – volume: 27 start-page: 915 issue: 6 year: 2021 ident: pmed.1003735.ref117 article-title: Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.02.025 – year: 2021 ident: pmed.1003735.ref225 article-title: Performance and operational evaluation of the Access Bio CareStart Rapid Antigen Test in a high-throughput drive-through community testing site in Massachusetts publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref222 article-title: COVID-19: rapid antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testing publication-title: medRxiv – volume: 27 start-page: 1323 issue: 5 year: 2020 ident: pmed.1003735.ref266 article-title: Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site publication-title: Emerg Infect Dis doi: 10.3201/eid2705.204688 – volume: 10 start-page: 328 issue: 2 year: 2021 ident: pmed.1003735.ref203 article-title: The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro publication-title: J Clin Med doi: 10.3390/jcm10020328 – year: 2021 ident: pmed.1003735.ref071 article-title: SARS-CoV-2 antigen rapid diagnostic test enhanced with silver amplification technology publication-title: medRxiv – volume: 110 start-page: 203 year: 2021 ident: pmed.1003735.ref195 article-title: Diagnostic accuracy and utility of SARS-CoV-2 antigen lateral flow assays in medical admissions with possible COVID-19 publication-title: J Hosp Infect doi: 10.1016/j.jhin.2021.01.018 – volume: 108 start-page: 231 year: 2021 ident: pmed.1003735.ref091 article-title: Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.04.065 – year: 2020 ident: pmed.1003735.ref284 article-title: Rapid SARS-CoV-2 antigen detection by immunofluorescence—a new tool to detect infectivity publication-title: medRxiv – volume: 36 start-page: e101 issue: 14 year: 2021 ident: pmed.1003735.ref073 article-title: Clinical application of the standard Q COVID-19 Ag Test for the detection of SARS-CoV-2 infection publication-title: J Korean Med Sci doi: 10.3346/jkms.2021.36.e101 – volume: 35 start-page: e23631 issue: 1 year: 2021 ident: pmed.1003735.ref042 article-title: Safety considerations for the use of Point-Of-Care diagnostics during SARS-CoV-2 pandemic publication-title: J Clin Lab Anal doi: 10.1002/jcla.23631 – volume: 21 start-page: 577 issue: 1 year: 2021 ident: pmed.1003735.ref045 article-title: Occupancy modeling and resampling overcomes low test sensitivity to produce accurate SARS-CoV-2 prevalence estimates publication-title: BMC Public Health doi: 10.1186/s12889-021-10609-y – volume: 37 start-page: 10 issue: Suppl 1 year: 2020 ident: pmed.1003735.ref030 article-title: Cochrane corner: rapid point-of-care antigen and molecular-based tests for the diagnosis of COVID-19 infection publication-title: Pan Afr Med J – year: 2021 ident: pmed.1003735.ref240 article-title: Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2 publication-title: medRxiv – year: 2020 ident: pmed.1003735.ref026 article-title: Nasopharyngeal Panbio COVID-19 antigen performed at point-of-care has a high sensitivity in symptomatic and asymptomatic patients with higher risk for transmission and older age publication-title: medRxiv – year: 2020 ident: pmed.1003735.ref287 article-title: Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: a prospective comparative clinical trial publication-title: medRxiv – volume: 180 start-page: 1447 issue: 11 year: 2020 ident: pmed.1003735.ref299 article-title: Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2020.3862 – volume: 21 start-page: 3596 issue: 8 year: 2021 ident: pmed.1003735.ref094 article-title: Vigilant: an engineered VirD2-Cas9 complex for lateral flow assay-based detection of SARS-CoV2 publication-title: Nano Lett doi: 10.1021/acs.nanolett.1c00612 – volume: 11 start-page: 10519 year: 2021 ident: pmed.1003735.ref238 article-title: Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study publication-title: Sci Rep doi: 10.1038/s41598-021-90026-8 – volume: 27 start-page: 613 issue: 4 year: 2020 ident: pmed.1003735.ref061 article-title: Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs publication-title: J Infect Chemother doi: 10.1016/j.jiac.2020.11.021 – volume: 10 start-page: 753 issue: 2 year: 2021 ident: pmed.1003735.ref176 article-title: A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care: a clinical performance study publication-title: Infect Dis Ther doi: 10.1007/s40121-021-00413-x – volume: 17 start-page: 177 issue: 1 year: 2020 ident: pmed.1003735.ref255 article-title: Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand publication-title: Virol J doi: 10.1186/s12985-020-01452-5 – year: 2020 ident: pmed.1003735.ref048 article-title: From more testing to smart testing: data-guided SARS-CoV-2 testing choices publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref054 article-title: Testing out of quarantine publication-title: medRxiv – year: 2020 ident: pmed.1003735.ref013 article-title: Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: a systematic meta-analysis of available data as per November 20, 2020 publication-title: medRxiv – volume: 9 start-page: e9 issue: 1 year: 2021 ident: pmed.1003735.ref086 article-title: Discrepancy in screening performances of different rapid test kits for SARS-CoV-2; a letter to editor publication-title: Arch Acad Emerg Med – volume: 137 start-page: 104785 year: 2021 ident: pmed.1003735.ref196 article-title: Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104785 – volume: 288 start-page: 114024 year: 2020 ident: pmed.1003735.ref268 article-title: Comparison of the SARS-CoV-2 rapid antigen test to the real star Sars-CoV-2 RT PCR kit publication-title: J Virol Methods doi: 10.1016/j.jviromet.2020.114024 – year: 2021 ident: pmed.1003735.ref115 article-title: Epidemiologic characteristics associated with SARS-CoV-2 antigen-based test results, rRT-PCR cycle threshold values, subgenomic RNA, and viral culture results from university testing publication-title: Clin Infect Dis – volume: 224 start-page: 539 issue: 5 year: 2021 ident: pmed.1003735.ref228 article-title: Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2021.01.002 – year: 2021 ident: pmed.1003735.ref025 article-title: Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test publication-title: medRxiv – volume: 26 start-page: 213 issue: 3 year: 2021 ident: pmed.1003735.ref212 article-title: SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department publication-title: Biomarkers doi: 10.1080/1354750X.2021.1876769 – volume: 3 start-page: 1981 issue: 6 year: 2020 ident: pmed.1003735.ref158 article-title: SARS-CoV-2 RapidPlex: a graphene-based multiplexed telemedicine platform for rapid and low-cost COVID-19 diagnosis and monitoring publication-title: Matter doi: 10.1016/j.matt.2020.09.027 – year: 2020 ident: pmed.1003735.ref157 article-title: A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry publication-title: J Proteins Proteom – year: 2021 ident: pmed.1003735.ref197 article-title: Performance of the BinaxNOW COVID-19 Antigen Card test relative to the SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction assay among symptomatic and asymptomatic healthcare employees publication-title: Infect Control Hosp Epidemiol – ident: pmed.1003735.ref022 – volume: 14 start-page: 435 year: 2021 ident: pmed.1003735.ref065 article-title: Evaluation of analytical performance of seven rapid antigen detection kits for detection of SARS-CoV-2 virus publication-title: Int J Gen Med doi: 10.2147/IJGM.S297762 – year: 2020 ident: pmed.1003735.ref110 article-title: Immunochromatographic test for the detection of SARS-CoV-2 in saliva publication-title: medRxiv – year: 2020 ident: pmed.1003735.ref162 article-title: Detection of the SARS-CoV-2 spike protein in saliva with Shrinky-Dink electrodes publication-title: medRxiv – volume: 223 start-page: 1139 issue: 7 year: 2020 ident: pmed.1003735.ref283 article-title: Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco publication-title: J Infect Dis doi: 10.1093/infdis/jiaa802 – volume: 82 start-page: 186 issue: 5 year: 2020 ident: pmed.1003735.ref250 article-title: Analytical and clinical performance of the Panbio COVID-19 antigen-detecting rapid diagnostic test publication-title: J Infect doi: 10.1016/j.jinf.2020.12.033 – year: 2021 ident: pmed.1003735.ref244 article-title: Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR publication-title: medRxiv – volume: 27 start-page: 1129 issue: 7 year: 2021 ident: pmed.1003735.ref230 article-title: Letter of concern re: “Immunochromatographic test for the detection of SARS-CoV-2 in saliva. J Infect Chemother. 2021 Feb;27(2):384–386. 10.1016/j.jiac.2020.11.016” publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.04.003 – volume: 2 start-page: e311 issue: 7 year: 2021 ident: pmed.1003735.ref256 article-title: Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests publication-title: Lancet Microbe doi: 10.1016/S2666-5247(21)00056-2 – volume: 174 start-page: 945 issue: 7 year: 2021 ident: pmed.1003735.ref124 article-title: Performance evaluation of serial SARS-CoV-2 rapid antigen testing during a nursing home outbreak publication-title: Ann Intern Med doi: 10.7326/M21-0422 – year: 2021 ident: pmed.1003735.ref131 article-title: Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection publication-title: medRxiv – ident: pmed.1003735.ref183 – volume: 176 start-page: 112912 year: 2021 ident: pmed.1003735.ref161 article-title: Paper-based electrochemical biosensor for diagnosing COVID-19: detection of SARS-CoV-2 antibodies and antigen publication-title: Biosens Bioelectron doi: 10.1016/j.bios.2020.112912 – volume: 49 start-page: 555 issue: 3 year: 2021 ident: pmed.1003735.ref069 article-title: Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values publication-title: Infection doi: 10.1007/s15010-020-01542-0 – volume: 82 start-page: 186 issue: 5 year: 2021 ident: pmed.1003735.ref248 article-title: Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs: a population-based point-of-care study publication-title: J Infect doi: 10.1016/j.jinf.2020.12.007 – volume: 27 start-page: 1734 issue: 6 year: 2021 ident: pmed.1003735.ref083 article-title: Rapid antigen test for postmortem evaluation of SARS-CoV-2 carriage publication-title: Emerg Infect Dis doi: 10.3201/eid2706.210226 – year: 2020 ident: pmed.1003735.ref152 article-title: Development of mass spectrometry-based targeted assay for direct detection of novel SARS-CoV-2 coronavirus from clinical specimens publication-title: medRxiv – volume: 372 start-page: n71 year: 2021 ident: pmed.1003735.ref297 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ doi: 10.1136/bmj.n71 – volume: 10 start-page: 265 issue: 2 year: 2021 ident: pmed.1003735.ref178 article-title: Head-to-head comparison of rapid and automated antigen detection tests for the diagnosis of SARS-CoV-2 infection publication-title: J Clin Med doi: 10.3390/jcm10020265 – volume: 22 start-page: 1176 issue: 7 year: 2021 ident: pmed.1003735.ref037 article-title: Optical biosensors for virus detection: prospects for SARS-CoV-2/COVID-19 publication-title: Chembiochem doi: 10.1002/cbic.202000744 – year: 2020 ident: pmed.1003735.ref156 article-title: Hitting the diagnostic sweet spot: point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer publication-title: medRxiv – volume: 58 start-page: e00977 issue: 8 year: 2020 ident: pmed.1003735.ref269 article-title: Evaluation of a rapid diagnostic assay for detection of SARS-CoV-2 antigen in nasopharyngeal swabs publication-title: J Clin Microbiol doi: 10.1128/JCM.00977-20 – volume: 16 start-page: e0249972 issue: 4 year: 2021 ident: pmed.1003735.ref121 article-title: Evaluation of rapid SARS-CoV-2 antigen tests, AFIAS COVID-19 Ag and ichroma COVID-19 Ag, with serial nasopharyngeal specimens from COVID-19 patients publication-title: PLoS ONE doi: 10.1371/journal.pone.0249972 – volume: 11 start-page: 6201 issue: 1 year: 2020 ident: pmed.1003735.ref135 article-title: Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts publication-title: Nat Commun doi: 10.1038/s41467-020-19925-0 – year: 2020 ident: pmed.1003735.ref082 article-title: Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva publication-title: medRxiv – year: 2020 ident: pmed.1003735.ref029 article-title: Development of a rapid test kit for SARS-CoV-2: an example of product design publication-title: Biodes Manuf – year: 2021 ident: pmed.1003735.ref175 article-title: Experience with Panbio™ rapid antigens test device for the detection of SARS-CoV-2 in nursing homes publication-title: Enferm Infecc Microbiol Clin (Engl Ed) – volume: 59 start-page: e03282 issue: 4 year: 2021 ident: pmed.1003735.ref217 article-title: Performance characteristics of BinaxNOW COVID-19 Antigen Card for screening asymptomatic individuals in a university setting publication-title: J Clin Microbiol doi: 10.1128/JCM.03282-20 – volume: 129 start-page: 104500 year: 2020 ident: pmed.1003735.ref275 article-title: Evaluation of rapid antigen test for detection of SARS-CoV-2 virus publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104500 – year: 2021 ident: pmed.1003735.ref301 article-title: Post-disease divergence in SARS-CoV-2 RNA detection between nasopharyngeal, anterior nares and saliva/oral fluid specimens—significant implications for policy & public health publication-title: medRxiv – volume: 413 start-page: 3501 year: 2021 ident: pmed.1003735.ref134 article-title: Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens publication-title: Anal Bioanal Chem doi: 10.1007/s00216-021-03298-4 – volume: 171 start-page: 112685 year: 2021 ident: pmed.1003735.ref144 article-title: One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device publication-title: Biosens Bioelectron doi: 10.1016/j.bios.2020.112685 – year: 2020 ident: pmed.1003735.ref150 article-title: eCovSens-ultrasensitive novel in-house built printed circuit board based electrochemical device for rapid detection of nCovid-19 publication-title: bioRxiv – volume: 27 start-page: 758 issue: 5 year: 2020 ident: pmed.1003735.ref276 article-title: Multicenter evaluation of the Panbio™ COVID-19 Rapid Antigen-Detection Test for the diagnosis of SARS-CoV-2 infection publication-title: Clin Microbiol Infect – year: 2020 ident: pmed.1003735.ref151 article-title: The impact of high frequency rapid viral antigen screening on COVID-19 spread and outcomes: a validation and modeling study publication-title: medRxiv – volume: 16 start-page: e0247606 issue: 2 year: 2021 ident: pmed.1003735.ref226 article-title: Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia publication-title: PLoS ONE doi: 10.1371/journal.pone.0247606 – year: 2021 ident: pmed.1003735.ref079 article-title: Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection publication-title: medRxiv – volume: 342 start-page: 129899 year: 2021 ident: pmed.1003735.ref164 article-title: rapid point-of-care testing for SARS-CoV-2 virus nucleic acid detection by an isothermal and nonenzymatic signal amplification system coupled with a lateral flow immunoassay strip publication-title: Sens Actuators B Chem doi: 10.1016/j.snb.2021.129899 – year: 2020 ident: pmed.1003735.ref280 article-title: Usefulness of the antigen for diagnosing SARS-CoV-2 infection in patients with and without symptoms publication-title: Enferm Infecc Microbiol Clin (Engl Ed) – volume: 104 start-page: 282 year: 2020 ident: pmed.1003735.ref278 article-title: Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.10.073 – volume: 14 start-page: 5135 issue: 4 year: 2020 ident: pmed.1003735.ref154 article-title: Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor publication-title: ACS Nano doi: 10.1021/acsnano.0c02823 – ident: pmed.1003735.ref003 – volume: 49 start-page: 789 issue: 4 year: 2021 ident: pmed.1003735.ref049 article-title: Rapid antigen testing and non-infectious shedding of SARS-Cov2 publication-title: Infection doi: 10.1007/s15010-020-01570-w – volume: 93 start-page: 1920 issue: 4 year: 2021 ident: pmed.1003735.ref126 article-title: Evaluation of PCL rapid point of care antigen test for detection of SARS-CoV-2 in nasopharyngeal swabs publication-title: J Med Virol doi: 10.1002/jmv.26765 – volume: 10 start-page: 38 issue: 1 year: 2020 ident: pmed.1003735.ref286 article-title: Limits and opportunities of SARS-CoV-2 antigen rapid tests—an experience based perspective publication-title: Pathogens doi: 10.3390/pathogens10010038 – volume: 105 start-page: P391 year: 2021 ident: pmed.1003735.ref189 article-title: Evaluation of automated test Lumipulse G SARS-CoV-2 antigen assay for detection of SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.02.098 – volume: 82 start-page: 276 year: 2021 ident: pmed.1003735.ref246 article-title: Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital publication-title: J Infect doi: 10.1016/j.jinf.2021.02.025 – year: 2020 ident: pmed.1003735.ref293 article-title: Performance evaluation of a SARS-CoV-2 rapid antigentest: test performance in the community in the Netherlands publication-title: medRxiv – volume: 9 start-page: 58 issue: 1 year: 2020 ident: pmed.1003735.ref236 article-title: Performance of a point-of-care test for the rapid detection of SARS-CoV-2 antigen publication-title: Microorganisms doi: 10.3390/microorganisms9010058 – ident: pmed.1003735.ref181 – volume: 153 start-page: 126 issue: 1 year: 2020 ident: pmed.1003735.ref264 article-title: Rapid chromatographic immunoassay-based evaluation of COVID-19: a cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India publication-title: Indian J Med Res – volume: 41 start-page: 483 issue: 3 year: 2020 ident: pmed.1003735.ref010 article-title: Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays publication-title: Reprod Biomed Online doi: 10.1016/j.rbmo.2020.06.001 – volume: 132 start-page: 104654 year: 2020 ident: pmed.1003735.ref254 article-title: Urgent need of rapid tests for SARS CoV-2 antigen detection: evaluation of the SD-Biosensor antigen test for SARS-CoV-2 publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104654 – year: 2021 ident: pmed.1003735.ref043 article-title: Issues of random sampling with rapid antigen tests for COVID-19 diagnosis: a special reference to Kalmunai RDHS Division publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref142 article-title: Development and evaluation of a new Swiss made SARS-CoV-2 antigen-detecting rapid test publication-title: medRxiv – volume: 149 start-page: 889 issue: 12 year: 2008 ident: pmed.1003735.ref014 article-title: Cochrane Diagnostic Test Accuracy Working Goup. Systematic reviews of diagnostic test accuracy publication-title: Ann Intern Med doi: 10.7326/0003-4819-149-12-200812160-00008 – year: 2020 ident: pmed.1003735.ref031 article-title: The effectiveness of population-wide, rapid antigen test based screening in reducing SARS-CoV-2 infection prevalence in Slovakia publication-title: medRxiv – year: 2020 ident: pmed.1003735.ref027 article-title: Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples publication-title: bioRxiv – volume: 27 start-page: 404 issue: 2 year: 2021 ident: pmed.1003735.ref046 article-title: Universal admission screening for SARS-CoV-2 infections among hospitalized patients, Switzerland, 2020 publication-title: Emerg Infect Dis doi: 10.3201/eid2702.202318 – year: 2021 ident: pmed.1003735.ref160 article-title: Ultra-sensitive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen detection for the diagnosis of coronavirus disease 2019 (COVID-19) in upper respiratory samples publication-title: Clin Infect Dis doi: 10.5772/intechopen.87410 – year: 2021 ident: pmed.1003735.ref147 article-title: Quantitative and ultrasensitive in-situ immunoassay technology for SARS-CoV-2 detection in saliva publication-title: Research Square – volume: 113 start-page: 851 issue: 12 year: 2020 ident: pmed.1003735.ref039 article-title: Utilizing point-of-care diagnostics to minimize nosocomial infection in the 2019 novel coronavirus (SARS-CoV-2) pandemic publication-title: QJM doi: 10.1093/qjmed/hcaa185 – year: 2020 ident: pmed.1003735.ref253 article-title: Evaluation of the Panbio™ rapid antigen test for SARS-CoV-2 in primary health care centers and test sites publication-title: medRxiv – volume: 82 start-page: 269 issue: 6 year: 2021 ident: pmed.1003735.ref167 article-title: Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison publication-title: J Infect doi: 10.1016/j.jinf.2021.04.009 – volume: 135 start-page: 104713 year: 2020 ident: pmed.1003735.ref291 article-title: Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread? publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104713 – volume: 134 start-page: 104712 year: 2021 ident: pmed.1003735.ref208 article-title: Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2 publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104712 – year: 2020 ident: pmed.1003735.ref257 article-title: The sensitivity of SARS-CoV-2 antigen tests in the view of large-scale testing publication-title: medRxiv – volume: 233 start-page: 283 year: 2021 ident: pmed.1003735.ref038 article-title: Diagnostic performance of antigen testing for SARS-CoV-2 publication-title: J Pediatr doi: 10.1016/j.jpeds.2021.02.052 – year: 2021 ident: pmed.1003735.ref137 article-title: Femtomolar SARS-CoV-2 antigen detection using the microbubbling digital assay with smartphone readout enables antigen burden quantitation and dynamics tracking publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref190 article-title: Differences in detected viral loads guide use of SARS-CoV-2 antigen-detection assays towards symptomatic college students and children publication-title: medRxiv – volume: 1154 start-page: 338310 year: 2021 ident: pmed.1003735.ref093 article-title: A novel one-pot rapid diagnostic technology for COVID-19 publication-title: Anal Chim Acta doi: 10.1016/j.aca.2021.338310 – ident: pmed.1003735.ref021 – year: 2020 ident: pmed.1003735.ref019 article-title: Real-life performance of a novel antigen detection test on nasopharyngeal specimens for SARS-CoV-2 infection diagnosis: a prospective study publication-title: medRxiv – volume: 21 start-page: 1052 issue: 8 year: 2021 ident: pmed.1003735.ref028 article-title: Rolling out COVID-19 antigen rapid diagnostic tests: the time is now publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(21)00152-3 – volume: 59 start-page: e02880 issue: 3 year: 2021 ident: pmed.1003735.ref282 article-title: Analytical sensitivity of the Abbott BinaxNOW COVID-19 Ag CARD publication-title: J Clin Microbiol doi: 10.1128/JCM.02880-20 – ident: pmed.1003735.ref182 – volume: 151 start-page: 264W64 issue: 4 year: 2009 ident: pmed.1003735.ref015 article-title: PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: Ann Intern Med doi: 10.7326/0003-4819-151-4-200908180-00135 – year: 2020 ident: pmed.1003735.ref034 article-title: Analysis of the specificity of the SD Biosensor Standard Q Ag-Test based on Slovak mass testing data publication-title: medRxiv – volume: 58 start-page: e01438 issue: 9 year: 2020 ident: pmed.1003735.ref072 article-title: Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19 publication-title: J Clin Microbiol doi: 10.1128/JCM.01438-20 – volume: 383 start-page: e120 issue: 22 year: 2020 ident: pmed.1003735.ref002 article-title: Rethinking Covid-19 test sensitivity—a strategy for containment publication-title: N Engl J Med doi: 10.1056/NEJMp2025631 – volume: 108 start-page: 187 year: 2021 ident: pmed.1003735.ref114 article-title: Comparative analysis of antigen and molecular tests for the detection of Sars-CoV-2 and related variants: a study on 4266 samples publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.04.048 – ident: pmed.1003735.ref187 – volume: 50 start-page: 2455 issue: 7 year: 2012 ident: pmed.1003735.ref005 article-title: Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics publication-title: J Clin Microbiol doi: 10.1128/JCM.00842-12 – volume: 12 start-page: 1420 issue: 12 year: 2020 ident: pmed.1003735.ref104 article-title: Comparison of rapid antigen tests for COVID-19 publication-title: Viruses doi: 10.3390/v12121420 – year: 2020 ident: pmed.1003735.ref024 article-title: Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19 publication-title: medRxiv – volume: 11 start-page: 115 issue: 1 year: 2021 ident: pmed.1003735.ref058 article-title: COVID-19 point-of-care diagnostics that satisfy global target product profiles publication-title: Diagnostics doi: 10.3390/diagnostics11010115 – volume: 27 start-page: 1058 issue: 7 year: 2021 ident: pmed.1003735.ref128 article-title: Accuracy of rapid antigen detection test for nasopharyngeal swab specimens and saliva samples in comparison with RT-PCR and viral culture for SARS-CoV-2 detection publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.04.010 – year: 2021 ident: pmed.1003735.ref223 article-title: Comparative performance of SARS-CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens publication-title: medRxiv – volume: 104 start-page: 65 year: 2021 ident: pmed.1003735.ref130 article-title: Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.12.079 – volume: 81 start-page: E75 issue: 3 year: 2020 ident: pmed.1003735.ref132 article-title: Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study publication-title: J Infect doi: 10.1016/j.jinf.2020.06.042 – volume: 73 start-page: S54 issue: Suppl 1 year: 2021 ident: pmed.1003735.ref127 article-title: Performance of repeat BinaxNOW SARS-CoV-2 antigen testing in a community setting, Wisconsin, November–December 2020 publication-title: Clin Infect Dis – volume: 137 start-page: 104782 year: 2020 ident: pmed.1003735.ref279 article-title: Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104782 – volume: 47 start-page: 17 issue: 1 year: 2021 ident: pmed.1003735.ref052 article-title: Interim guidance on the use of the Abbott Panbio™ COVID-19 Antigen Rapid Test publication-title: Can Commun Dis Rep doi: 10.14745/ccdr.v47i01a04 – year: 2021 ident: pmed.1003735.ref171 article-title: The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients publication-title: medRxiv – volume: 27 start-page: 319 issue: 2 year: 2021 ident: pmed.1003735.ref113 article-title: Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline SARS-CoV-2 publication-title: J Infect Chemother doi: 10.1016/j.jiac.2020.11.015 – year: 2020 ident: pmed.1003735.ref149 article-title: Ultra-sensitive nanozyme-based chemiluminescence paper test for rapid diagnosis of SARS-CoV-2 infection publication-title: bioRxiv – volume: 1 start-page: 100013 issue: 1–2 year: 2021 ident: pmed.1003735.ref165 article-title: Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the Eastern Cape, South Africa publication-title: J Clin Virol Plus doi: 10.1016/j.jcvp.2021.100013 – volume: 13 start-page: 684 issue: 4 year: 2021 ident: pmed.1003735.ref194 article-title: Five antigen tests for SARS-CoV-2: virus viability matters publication-title: Viruses doi: 10.3390/v13040684 – year: 2021 ident: pmed.1003735.ref229 article-title: Clinical assessment of the Roche SARS-CoV-2 rapid antigen test publication-title: Diagnosis (Berl) – ident: pmed.1003735.ref261 – year: 2020 ident: pmed.1003735.ref138 article-title: COVID-19 antigen rapid test as screening strategy at the points-of-entry: experience in Lazio region, central Italy, August–October 2020 publication-title: medRxiv – volume: 82 start-page: 282 issue: 2 year: 2021 ident: pmed.1003735.ref098 article-title: Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers publication-title: J Infect doi: 10.1016/j.jinf.2021.01.008 – year: 2021 ident: pmed.1003735.ref207 article-title: SARS-CoV-2 patient self-testing with an antigen-detecting rapid test: a head-to-head comparison with professional testing publication-title: medRxiv – volume: 9 start-page: 100115 year: 2021 ident: pmed.1003735.ref213 article-title: Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: a validation and implementation study publication-title: Lancet Reg Health West Pac doi: 10.1016/j.lanwpc.2021.100115 – year: 2020 ident: pmed.1003735.ref290 article-title: SARS-CoV-2 qRT-PCR Ct value distribution in Japan and possible utility of rapid antigen testing kit publication-title: medRxiv – volume: 15 start-page: 93 issue: 2 year: 2021 ident: pmed.1003735.ref070 article-title: Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease publication-title: Biosci Trends doi: 10.5582/bst.2021.01090 – volume: 93 start-page: 3152 issue: 5 year: 2021 ident: pmed.1003735.ref064 article-title: High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection publication-title: J Med Virol doi: 10.1002/jmv.26896 – volume: 129 start-page: 104472 year: 2020 ident: pmed.1003735.ref109 article-title: Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: experiences of a general hospital publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104472 – year: 2020 ident: pmed.1003735.ref051 article-title: Characteristic spatial scales of SARS-CoV-2 pandemics: lessons from mass rapid antigen testing in Slovakia publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref233 article-title: The value of rapid antigen tests to identify carriers of viable SARS-CoV-2 publication-title: medRxiv – volume: 372 start-page: n208 year: 2021 ident: pmed.1003735.ref053 article-title: Put to the test: use of rapid testing technologies for covid-19 publication-title: BMJ doi: 10.1136/bmj.n208 – year: 2021 ident: pmed.1003735.ref080 article-title: Real-world clinical performance of the Abbott Panbio with nasopharyngeal, throat and saliva swabs among symptomatic individuals with COVID-19 publication-title: medRxiv – volume: 293 start-page: 114166 year: 2021 ident: pmed.1003735.ref084 article-title: Development and performance characteristics evaluation of a new Bioelectric Recognition Assay (BERA) method for rapid Sars-CoV-2 detection in clinical samples publication-title: J Virol Methods doi: 10.1016/j.jviromet.2021.114166 – volume: 40 start-page: 1721 issue: 8 year: 2021 ident: pmed.1003735.ref235 article-title: Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-021-04202-9 – volume: 59 start-page: e02589 year: 2020 ident: pmed.1003735.ref258 article-title: Evaluation of the Panbio Covid-19 rapid antigen detection test device for the screening of patients with Covid-19 publication-title: J Clin Microbiol – year: 2020 ident: pmed.1003735.ref004 article-title: Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2 publication-title: medRxiv – volume: 133 start-page: 104659 year: 2020 ident: pmed.1003735.ref270 article-title: Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104659 – volume: 293 start-page: 114165 year: 2021 ident: pmed.1003735.ref200 article-title: Comparison of four PCR and two point of care assays used in the laboratory detection of SARS-CoV-2 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2021.114165 – year: 2021 ident: pmed.1003735.ref204 article-title: Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™-Antigen-detecting point-of-care device for SARS-CoV-2 publication-title: medRxiv – volume: 59 start-page: 1468 issue: 8 year: 2021 ident: pmed.1003735.ref210 article-title: Lumipulse G SARS-CoV-2 Ag Assay evaluation for SARS-CoV-2 antigen detection using 594 nasopharyngeal swab samples from different testing groups publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2021-0182 – year: 2021 ident: pmed.1003735.ref087 article-title: Weekly SARS-CoV-2 screening of asymptomatic students and staff to guide and evaluate strategies for safer in-person learning publication-title: medRxiv – volume: 104 start-page: 159 year: 2020 ident: pmed.1003735.ref092 article-title: False positive results of IgM/IgG antibodies against antigen of the SARS-CoV-2 in sera stored before the 2020 Endemia in Italy publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.12.067 – volume: 59 start-page: e0037421 issue: 7 year: 2021 ident: pmed.1003735.ref206 article-title: Comparison of the quantitative DiaSorin Liaison antigen test to RT-PCR for the diagnosis of COVID-19 in symptomatic and asymptomatic outpatients publication-title: J Clin Microbiol doi: 10.1128/JCM.00374-21 – volume: 9 start-page: 1255 issue: 1 year: 2020 ident: pmed.1003735.ref008 article-title: COVID-19 rapid diagnostic test could contain transmission in low- and middle-income countries publication-title: Afr J Lab Med doi: 10.4102/ajlm.v9i1.1255 – year: 2020 ident: pmed.1003735.ref020 article-title: Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein publication-title: medRxiv – volume: 4 start-page: 1121 issue: 12 year: 2020 ident: pmed.1003735.ref055 article-title: Rapid and frequent testing publication-title: Nat Biomed Eng doi: 10.1038/s41551-020-00670-0 – volume: 59 start-page: e02727 issue: 2 year: 2020 ident: pmed.1003735.ref251 article-title: Comparison of Quidel Sofia SARS FIA Test to Hologic Aptima SARS-CoV-2 TMA Test for diagnosis of COVID-19 in symptomatic outpatients publication-title: J Clin Microbiol – volume: 70 start-page: 100 issue: 3 year: 2021 ident: pmed.1003735.ref112 article-title: Evaluation of Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection at two community-based testing sites—Pima County, Arizona, November 3–17, 2020 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm7003e3 – year: 2020 ident: pmed.1003735.ref123 article-title: Rapid detection of SARS-CoV-2 antigen from serum in a hospitalized population publication-title: medRxiv – volume: 1146 start-page: 184 year: 2021 ident: pmed.1003735.ref033 article-title: A critical review of point-of-care diagnostic technologies to combat viral pandemics publication-title: Anal Chim Acta doi: 10.1016/j.aca.2020.10.009 – year: 2020 ident: pmed.1003735.ref298 article-title: SARS-CoV-2 viral dynamics in acute infections publication-title: medRxiv – volume: 18 start-page: 34 issue: 1 year: 2021 ident: pmed.1003735.ref078 article-title: Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy publication-title: Virol J doi: 10.1186/s12985-021-01505-3 – volume: 10 start-page: 594 issue: 8 year: 2020 ident: pmed.1003735.ref145 article-title: Proposal of de novo antigen test for COVID-19: ultrasensitive detection of spike proteins of SARS-CoV-2 publication-title: Diagnostics (Basel) doi: 10.3390/diagnostics10080594 – year: 2021 ident: pmed.1003735.ref180 article-title: COVID-19 rapid antigen test at hospital admission associated to the knowledge of individual risk factors allow overcoming the difficulty of managing suspected patients in hospitals COVID-19 rapid antigen test facilitates the management of suspected patients on hospital admission publication-title: medRxiv – ident: pmed.1003735.ref185 – volume: 105 start-page: 7 year: 2021 ident: pmed.1003735.ref193 article-title: Prospective study of 1,308 nasopharyngeal swabs from 1,033 patients using the LUMIPULSE SARS-CoV-2 antigen test: comparison with RT-qPCR publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.02.005 – year: 2021 ident: pmed.1003735.ref050 article-title: Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus publication-title: medRxiv – volume: 18 start-page: 36 issue: 2 year: 2020 ident: pmed.1003735.ref289 article-title: Sensitivity and specificity of lateral flow antigen test kits for COVID-19 in asymptomatic population of quarantine centre of province 3 publication-title: Kathmandu Univ Med J (KUMJ) doi: 10.3126/kumj.v18i2.32942 – year: 2020 ident: pmed.1003735.ref265 article-title: Testing of healthcare workers exposed to COVID19 with rapid antigen detection publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref101 article-title: Low sensitivity of rapid antigenic tests as a screening method in an outbreak of SARS-CoV-2 infection in prison publication-title: Enferm Infecc Microbiol Clin (Engl Ed) – year: 2020 ident: pmed.1003735.ref267 article-title: Evaluation of the accuracy and ease-of-use of Abbott PanBio—a WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2 publication-title: medRxiv – volume: 129 start-page: 104455 year: 2020 ident: pmed.1003735.ref288 article-title: Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104455 – year: 2021 ident: pmed.1003735.ref103 article-title: SARS-CoV-2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref177 article-title: Evaluation of the Panbio™ COVID-19 Ag Rapid Test at an emergency room in a hospital in São Paulo, Brazil publication-title: medRxiv – year: 2020 ident: pmed.1003735.ref281 article-title: Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture publication-title: Clin Infect Dis – volume: 69 start-page: 1642 issue: 5152 year: 2021 ident: pmed.1003735.ref125 article-title: Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses—Wisconsin, September–October 2020 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm695152a3 – volume: 99 start-page: 328 year: 2020 ident: pmed.1003735.ref285 article-title: Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.05.098 – year: 2020 ident: pmed.1003735.ref100 article-title: At-home self-testing of teachers with a SARS-CoV-2 rapid antigen test to reduce potential transmissions in schools publication-title: medRxiv – ident: pmed.1003735.ref262 – volume: 10 start-page: 553837 year: 2020 ident: pmed.1003735.ref163 article-title: Foundation and clinical evaluation of a new method for detecting SARS-CoV-2 antigen by fluorescent microsphere immunochromatography publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2020.553837 – ident: pmed.1003735.ref186 – volume: 24 start-page: 180 issue: 2 year: 2020 ident: pmed.1003735.ref009 article-title: COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil publication-title: Braz J Infect Dis doi: 10.1016/j.bjid.2020.04.003 – year: 2020 ident: pmed.1003735.ref129 article-title: Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio™ COVID-19 Antigen Rapid Test (Abbott) compared to RT-qPCR publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref205 article-title: Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting publication-title: medRxiv – year: 2021 ident: pmed.1003735.ref076 article-title: Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection publication-title: medRxiv – volume: 137 start-page: 104789 year: 2021 ident: pmed.1003735.ref122 article-title: Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104789 – year: 2021 ident: pmed.1003735.ref201 article-title: Accuracy of antigen and nucleic acid amplification testing on saliva and naopharyngeal samples for detection of SARS-CoV-2 in ambulatory care publication-title: medRxiv – volume: 27 start-page: 487 year: 2020 ident: pmed.1003735.ref273 article-title: Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.09.030 – volume: 22 start-page: S37 issue: 11 year: 2020 ident: pmed.1003735.ref095 article-title: Development of a multiplexed synthetic control for rapid detection of SARS-CoV-2 and other respiratory pathogens using a nucleic acid syndromic testing panel publication-title: J Mol Diagnostics – year: 2021 ident: pmed.1003735.ref068 article-title: Sensitivity of rapid antigen testing and RT-PCR performed on nasopharyngeal swabs versus saliva samples in COVID-19 hospitalized patients: results of a prospective comparative trial (RESTART) publication-title: medRxiv – volume: 19 start-page: 75 year: 2020 ident: pmed.1003735.ref153 article-title: Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis publication-title: BMC Med doi: 10.1186/s12916-021-01948-z – volume: 26 start-page: 2100413 issue: 16 year: 2021 ident: pmed.1003735.ref198 article-title: Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2021.26.16.2100413 – volume: 52 start-page: e46 year: 2020 ident: pmed.1003735.ref060 article-title: Potential use of antigen-based rapid test for SARS-CoV-2 in respiratory specimens in low-resource settings in Egypt for symptomatic patients and high-risk contacts publication-title: Lab Med doi: 10.1093/labmed/lmaa104 – year: 2021 ident: pmed.1003735.ref085 article-title: The limit of detection matters: the case for benchmarking severe acute respiratory syndrome coronavirus 2 testing publication-title: Clin Infect Dis – volume: 6 start-page: 6643 issue: 10 year: 2021 ident: pmed.1003735.ref148 article-title: MXene-graphene field-effect transistor sensing of influenza virus and SARS-CoV-2 publication-title: ACS Omega doi: 10.1021/acsomega.0c05421 – volume: 57 start-page: 2003961 issue: 4 year: 2021 ident: pmed.1003735.ref272 article-title: Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab publication-title: Eur Respir J doi: 10.1183/13993003.03961-2020 – volume: 11 start-page: 698 issue: 4 year: 2021 ident: pmed.1003735.ref140 article-title: Detection of SARS-COV-2 proteins using an ELISA test publication-title: Diagnostics (Basel) doi: 10.3390/diagnostics11040698 – volume: 39 start-page: 101942 year: 2020 ident: pmed.1003735.ref295 article-title: Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium publication-title: Travel Med Infect Dis doi: 10.1016/j.tmaid.2020.101942 – year: 2021 ident: pmed.1003735.ref220 article-title: Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals publication-title: medRxiv – volume: 93 start-page: 4405 issue: 7 year: 2021 ident: pmed.1003735.ref102 article-title: Field evaluation of COVID-19 antigen tests versus RNA based detection: potential lower sensitivity compensated by immediate results, technical simplicity and low cost publication-title: J Med Virol doi: 10.1002/jmv.26985 – volume: 155 start-page: 529 issue: 8 year: 2011 ident: pmed.1003735.ref017 article-title: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies publication-title: Ann Intern Med doi: 10.7326/0003-4819-155-8-201110180-00009 – year: 2021 ident: pmed.1003735.ref090 article-title: A prospective evaluation of the analytical performance of GENECUBE HQ SARS-CoV-2 and GENECUBE FLU A/B publication-title: medRxiv – volume: 27 start-page: 1089 issue: 7 year: 2021 ident: pmed.1003735.ref111 article-title: False positive results in severe acute respiratory coronavirus 2 (SARS-CoV-2) rapid antigen tests for inpatients publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.03.011 – reference: 34644309 - PLoS Med. 2021 Oct 13;18(10):e1003825. doi: 10.1371/journal.pmed.1003825 |
| SSID | ssj0029090 |
| Score | 2.6828344 |
| SecondaryResourceType | review_article |
| Snippet | SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs have shown... Background SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs... Lukas Brümmer and co-workers report on the accuracy of rapid antigen tests for SARS-CoV-2. BackgroundSARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs... Background SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) are increasingly being integrated in testing strategies around the world. Studies of the Ag-RDTs... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e1003735 |
| SubjectTerms | Accuracy Age Factors Age groups Antigens Antigens, Viral - analysis Bias Biology and life sciences Carrier State - diagnosis Carrier State - virology Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 - etiology COVID-19 Serological Testing - methods COVID-19 Serological Testing - standards Disease transmission Humans Medicine and Health Sciences Meta-analysis Nasopharynx - virology Physical Sciences Polymerase chain reaction Reagent Kits, Diagnostic Reference Standards Research and Analysis Methods Reverse transcription Reviews SARS-CoV-2 - immunology Sensitivity and Specificity Severe acute respiratory syndrome coronavirus 2 Standardization Systematic review Viral Load |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZQhRAviN8LDDAIwZNZEjtxzFuYmOCBglaY9hY5jr1VKknVtJP477lL3GxBlbYHXvpQf07VO9_5HN99R8hbpRMNG4VjWsiSCazRLbXQTEihMlPFSDnXNZuQ02l2eqp-XGn1hTlhPT1wL7gDU6UJtxJ2rlIJJ0UWOpWlkYPAQoap63g-Q6m2hyl_1FJh93YF-cdYFEvpi-a4jA68jj4sYbfBHAEuu1Zvl5tSx90_eOjJctG0u8LPf7Mor2xLR_fJPR9P0rz_Hw_ILVs_JHe--RvzR-Q8N2az0uYPbRytmwu7oCBLpOCkK72cV7Tqc-2QrZlCAEtn-fGMHTYnLP5Ic7qY4wsHesn3TPtaF3hIRX_btWbas5o8Jr-OPv88_MJ8dwVmMh6umYiES6XTPHGY5mplWcUQ-8kk0mD28Gm1k7Y01sEZyzpembRMFBc2jnUmuONPyKRuartHqI2txftrE4ZOOAdewoYu5RArCCd0pgPCt-ItjKcexw4Yi6K7T5NwBOmlVaBSCq-UgLBh1rKn3rgG_wk1N2CROLv7ApZT4ZdTcd1yCsgr1HvRV6EO5l_kKdL8wDz4mTcdAskzaszOOdObti2-fj-5AWg2vQnoeAR670GuAZkZ7csmQPLI3DVCvhshz3re8l3A_REQHIoZDe_hmt_KuC3Aq3MBkXYkYebWDnYPvx6G8aGYv1fbZoMYJJxVkYgC8rQ3m0FPHNlyIXANiBwZ1EiR45F6ft4xoWcQbmdCPfsfmn9O7saYr4R0x_E-maxXG_uC3DYX63m7etm5l7_dT3sF priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFLegIMSFb1hhgEEITmZJ7MYJFxQmJjhQ0ApTb5Hj2F2lLumSdhL_Pe8lbkpQBZO49FD_nKZ-fh-2n3-PkFexGilwFJYpITMm8I5upoRiQoo40nmAlHNNsQk5HkfTafzNbbjVLq1yYxMbQ52XGvfID2BqcQHu3pfvl-cMq0bh6aoroXGVXMOy2TjP5XS74Iq9Zo8FWciYH0jprs5x6R84Sb1dgs_BTAEum4JvW9fUMPh3dnqwXJT1riD0z1zK35zT0e3__Vt3yC0XltKknUd3yRVT3CM3vriD9_vkNNF6XSn9k5aWFuWFWVAQCTJ50kot5znN25Q9JH2mEAfTSXI8YYflCQve0YQu5rhvQbe00bS9MgMPyemZWSmmHDnKA_Lj6OP3w0_MFWlgOuLeiglf2FBaxUcWs2WNzPIAQkg58hVYD_g0ykqTaWNhqWYsz3WYjWIuTBCoSHDLH5JBURZmj1ATGIPH4NrzrLAWjI3xbMgh5BBWqEgNCd_IJ9WOwRwLaSzS5lhOwkqmHa0UpZo6qQ4J63otWwaPf-A_oOg7LPJvN1-U1Sx16pzqPBxxeFkI-mNhpYg8G0ehbyHclV5o-ZA8x4mTtpdZOyuSJiGyBUE_-JmXDQI5OApM8pmpdV2nn7-eXAI0GV8GdNwDvXEgW8KYaeVuX8DIIwFYD_m6h5y19Oe7gPs9INgl3WveQ6XZjHGdbqc69Nwow-7mF10zPhTTAAtTrhGDvLWxL_whedTqXScnjqS7EP8OiexpZE-Q_ZZiftoQqkcQtUcifvz313pCbgaY0IR8yME-GayqtXlKruuL1byunjWW5xeBZ4o_ priority: 102 providerName: ProQuest |
| Title | Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34383750 https://www.proquest.com/docview/2573454517 https://www.proquest.com/docview/2561489141 https://pubmed.ncbi.nlm.nih.gov/PMC8389849 https://doaj.org/article/cd653e7081b94f7480f9861f508706f3 http://dx.doi.org/10.1371/journal.pmed.1003735 |
| Volume | 18 |
| WOSCitedRecordID | wos000684390300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: 7X7 dateStart: 20041001 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: BENPR dateStart: 20041001 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: PIMPY dateStart: 20041001 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: FPL dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELZYhxAv_IYVRjEIwVMgiZ044S2bVjGJlaqFqXuKXMfeKpWkatpJ_PfcJW5Gpk6MlzzEnxPrnDvfxXefCXkfy0DCQmEcycXU4VijO5VcOlzwOFKZj5Rz1WETYjCIJpN4eBUoXtvBZ8L7bGX6aQGrA-7pM8GCHbLrszDEYKs__NYEWLEbu7Y87qaereWnYulvbHFnMS_KbY7m9XzJvxag_sP_Hfoj8sC6mjSpv43H5I7On5B7J3Yz_Sm5SJRaL6X6TQtD8-JSzymIGdk56VIuZhnN6jQ8JHKm4NvScTIaO4fFqeN_oQmdz_BfBL2igqZ1GQw8JKO_9Eo60hKePCM_-0c_Dr869uAFR0XMXTnc4yYURrLAYAasFtPMB7dQBJ4EiwBXLY3QU6UNhF_asEyF0yBmXPu-jDgz7Dnp5EWu9wjVvta4ta1c13BjwIBo14QM3AhuuIxkl7DNfKTKspLj4RjztNpqExCd1NJKUYipFWKXOE2vRc3K8Q_8AU51g0VO7eoGzFZqVTRVWRgwGCw48jE3gkeuiaPQM-DCCjc0rEve4IeS1gWqjWVIkxAZgKAfvOZdhUBejRwTd87luizT4--ntwCNB7cBjVqgjxZkCpCZkraiAiSPpF4t5IcW8rymNN8G3G8BwdaoVvMeKslGxmUKBp9xcMI9AT03irO9-W3TjA_F1L5cF2vEIBdt7HGvS17UetbME0MiXfBpu0S0NLA1ke2WfHZRkaRH4IlHPH5584hfkfs-Jighv7G_Tzqr5Vq_JnfV5WpWLntkR0xEdY16ZPfgaDAc9aofNr3K5sC94fHJ8OwPdIx8rg |
| linkProvider | Public Library of Science |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELZKQMCFNzRQqEE8Tqa7a2e9i4RQKFSN2gbUlCq3xfHaaaSwG_Io6p_iNzKzr7Aogl564JJD_HmzscfjGXvmG0Keh6qlYKOwTAk5YAJzdAdKKCakCAMde0g5lxWbkN1u0O-Hn9fIzzIXBsMqS52YKeo41XhGvgWixQVs9658N_nOsGoU3q6WJTRysdgzZz_AZZu97XyA-X3heTsfj7Z3WVFVgOmAO3MmXGF9aRVvWQzvNHIQe2DzyJarQNzh0ygrzUAbC76FsTzW_qAVcmE8TwWCWw7PvUQugx6X6OzJ_tLBC53sTAdZz5jrSVmk6nHpbhWS8XoCexxGJnCZFZhbboVZxYBqX2hMxulsldH7Z-zmb5vhzs3_bRhvkRuF2U3b-Tq5TdZMcodcPSgCC-6Sk7bWi6nSZzS1NElPzZiCyCFTKZ2qySimcR6SiKTWFOx82msf9th2esy8N7RNxyM8l6FLWmyapwTBQ2L6zcwVUwX5yz3y5UL-533SSNLErBNqPGPwml87jhXWgjI1jvU5mFTCChWoJuGlPES6YGjHQiHjKLt2lOCp5aMVoRRFhRQ1Cat6TXKGkn_g36OoVVjkF8--SKfDqFBXkY79FoeXBacmFFaKwLFh4LsWzHnp-JY3ySYKapQn61ZaMmr7yIYE_eBnnmUI5BhJMIhpqBazWdT5dHwOUK97HtBhDfSqANkUxkyrIrsERh4JzmrIlzXkMKd3XwXcqAFB7-pa8zou0nKMZ9FyaUHPcvGtbn5aNeNDMcwxMekCMcjLG7rCbZIH-Tqv5okjqTDY900iaxqgNpH1lmR0khHGB-CVBCJ8-PfX2iTXdo8O9qP9TnfvEbnuYfAWcj97G6Qxny7MY3JFn85Hs-mTTOtR8vWi9cMvXvfnmw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELdGhyZe-IYVBjOIj6fQJHbjBAmhsjFRjZVqHdN4Cq5jd5VKUvoxtH-Nv467xE0JqmAve-ClD_XPbmqfz3fO3e8IeRbJpoSDwjiSi77DMUe3L7l0uOBRqBIfKefyYhOi0wlPTqLuGvm5yIXBsMqFTswVdZIpvCNvgGgxDse9JxrGhkV0d_fejr87WEEK37QuymkUIrKvz3-A-zZ9096FtX7u-3vvj3Y-OLbCgKNC5s4c7nETCCNZ02Copxb9xAf7RzQ9CaIPn1oaoftKG_AztGGJCvrNiHHt-zLkzDAY9wpZB5Oc-zWy3m0fdL-U7l7k5jc8yIHmeL4QNnGPCa9h5eTVGE48jFNgIi83tzwY8_oB5SlRG4-y6SoT-M9Izt-Oxr0b__Ok3iTXrUFOW8UOukXWdHqbbBzYkIM75LSl1Hwi1TnNDE2zMz2iIIzIYUoncjxMaFIEKyLdNQUPgPZahz1nJzt2_Ne0RUdDvLGhS8JsWiQLwSAJ_aZn0pGWFuYu-Xwp__MeqaVZqjcJ1b7WGACgXNdwY0DNatcEDIwtbrgMZZ2whWzEynK3YwmRUZy_kBTgwxWzFaNExVai6sQpe40L7pJ_4N-h2JVYZB7Pv8gmg9gqslglQZPBw4K7E3EjeOiaKAw8A4a-cAPD6mQbhTYu0nhL_Rm3AuRJgn7wM09zBLKPpChyAzmfTuP2p-MLgHqdi4AOK6CXFmQymDMlbd4JzDxSn1WQLyrIQUH8vgq4VQGCRlaV5k3csIs5nsbLbQY9FxtxdfOTshkHxQDIVGdzxCBjb-Rxr07uF3u-XCeGdMNg-deJqGiDykJWW9LhaU4lH4K_EvLowd8fa5tsgFqIP7Y7-w_JNR-jupAU2t8itdlkrh-Rq-psNpxOHlsVSMnXy1YQvwBrGPHq |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accuracy+of+novel+antigen+rapid+diagnostics+for+SARS-CoV-2%3A+A+living+systematic+review+and+meta-analysis&rft.jtitle=PLoS+medicine&rft.au=Br%C3%BCmmer%2C+Lukas+E&rft.au=Katzenschlager%2C+Stephan&rft.au=Gaeddert%2C+Mary&rft.au=Erdmann%2C+Christian&rft.date=2021-08-12&rft.issn=1549-1676&rft.eissn=1549-1676&rft.volume=18&rft.issue=8&rft.spage=e1003735&rft_id=info:doi/10.1371%2Fjournal.pmed.1003735&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon |